Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers

Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biologica...

Full description

Saved in:
Bibliographic Details
Published inNon-coding RNA research Vol. 9; no. 4; pp. 1351 - 1362
Main Authors Li, Yongxing, Tang, Xiaoqi, Wang, Binpan, Chen, Ming, Zheng, Ji, Chang, Kai
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.12.2024
KeAi Communications Co., Ltd
Subjects
Biomarkers
Exosomes
Modulators
Non-coding RNAs
Prostate cancer
Biomarkers
Non-coding RNAs
Exosomes
Prostate cancer
Modulators
Online AccessGet full text
ISSN2468-0540
2468-0540
DOI10.1016/j.ncrna.2024.07.003

Cover

Abstract Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biological behavior of PCa. Compared with circulating ncRNAs, ncRNAs loaded into exosomes are more stable because of protection by the lipid bilayer. Furthermore, exosomal ncRNAs facilitate the intercellular transfer of molecules and information. Increasing evidence suggests that exosomal ncRNAs hold promising potential in the progression, diagnosis and prognosis of PCa. This review aims to discuss the functions of exosomal ncRNAs in PCa, evaluate their possible applications as clinical biomarkers and therapeutic targets, and provide a comprehensive overview of the ncRNAs regulatory network in PCa. We also identified ncRNAs that can be utilized as biomarkers for diagnosis, staging, grading and prognosis assessment in PCa. This review offers researchers a fresh perspective on the functions of exosomal ncRNAs in PCa and provides additional options for its diagnosis, progression monitoring, and prognostic prediction. In prostate cancer (PCa), non-coding RNAs (ncRNAs) are transferred from donor cells to recipient cells via exosomes and involved in gene expression through various mechanisms. Due to the regulative effects of exosomal ncRNAs on physiological and pathological processes, they are potential biomarkers and promising therapeutic tools in PCa. [Display omitted]
AbstractList Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biological behavior of PCa. Compared with circulating ncRNAs, ncRNAs loaded into exosomes are more stable because of protection by the lipid bilayer. Furthermore, exosomal ncRNAs facilitate the intercellular transfer of molecules and information. Increasing evidence suggests that exosomal ncRNAs hold promising potential in the progression, diagnosis and prognosis of PCa. This review aims to discuss the functions of exosomal ncRNAs in PCa, evaluate their possible applications as clinical biomarkers and therapeutic targets, and provide a comprehensive overview of the ncRNAs regulatory network in PCa. We also identified ncRNAs that can be utilized as biomarkers for diagnosis, staging, grading and prognosis assessment in PCa. This review offers researchers a fresh perspective on the functions of exosomal ncRNAs in PCa and provides additional options for its diagnosis, progression monitoring, and prognostic prediction.
Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biological behavior of PCa. Compared with circulating ncRNAs, ncRNAs loaded into exosomes are more stable because of protection by the lipid bilayer. Furthermore, exosomal ncRNAs facilitate the intercellular transfer of molecules and information. Increasing evidence suggests that exosomal ncRNAs hold promising potential in the progression, diagnosis and prognosis of PCa. This review aims to discuss the functions of exosomal ncRNAs in PCa, evaluate their possible applications as clinical biomarkers and therapeutic targets, and provide a comprehensive overview of the ncRNAs regulatory network in PCa. We also identified ncRNAs that can be utilized as biomarkers for diagnosis, staging, grading and prognosis assessment in PCa. This review offers researchers a fresh perspective on the functions of exosomal ncRNAs in PCa and provides additional options for its diagnosis, progression monitoring, and prognostic prediction.Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biological behavior of PCa. Compared with circulating ncRNAs, ncRNAs loaded into exosomes are more stable because of protection by the lipid bilayer. Furthermore, exosomal ncRNAs facilitate the intercellular transfer of molecules and information. Increasing evidence suggests that exosomal ncRNAs hold promising potential in the progression, diagnosis and prognosis of PCa. This review aims to discuss the functions of exosomal ncRNAs in PCa, evaluate their possible applications as clinical biomarkers and therapeutic targets, and provide a comprehensive overview of the ncRNAs regulatory network in PCa. We also identified ncRNAs that can be utilized as biomarkers for diagnosis, staging, grading and prognosis assessment in PCa. This review offers researchers a fresh perspective on the functions of exosomal ncRNAs in PCa and provides additional options for its diagnosis, progression monitoring, and prognostic prediction.
Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs (ncRNAs), such as microRNAs, long non-coding RNAs and circular RNAs, frequently exhibit dysregulation and substantially impact the biological behavior of PCa. Compared with circulating ncRNAs, ncRNAs loaded into exosomes are more stable because of protection by the lipid bilayer. Furthermore, exosomal ncRNAs facilitate the intercellular transfer of molecules and information. Increasing evidence suggests that exosomal ncRNAs hold promising potential in the progression, diagnosis and prognosis of PCa. This review aims to discuss the functions of exosomal ncRNAs in PCa, evaluate their possible applications as clinical biomarkers and therapeutic targets, and provide a comprehensive overview of the ncRNAs regulatory network in PCa. We also identified ncRNAs that can be utilized as biomarkers for diagnosis, staging, grading and prognosis assessment in PCa. This review offers researchers a fresh perspective on the functions of exosomal ncRNAs in PCa and provides additional options for its diagnosis, progression monitoring, and prognostic prediction. In prostate cancer (PCa), non-coding RNAs (ncRNAs) are transferred from donor cells to recipient cells via exosomes and involved in gene expression through various mechanisms. Due to the regulative effects of exosomal ncRNAs on physiological and pathological processes, they are potential biomarkers and promising therapeutic tools in PCa. [Display omitted]
Author Zheng, Ji
Chen, Ming
Wang, Binpan
Tang, Xiaoqi
Li, Yongxing
Chang, Kai
Author_xml – sequence: 1
  givenname: Yongxing
  surname: Li
  fullname: Li, Yongxing
  organization: Department of Clinical Laboratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
– sequence: 2
  givenname: Xiaoqi
  surname: Tang
  fullname: Tang, Xiaoqi
  organization: Department of Clinical Laboratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
– sequence: 3
  givenname: Binpan
  surname: Wang
  fullname: Wang, Binpan
  organization: Department of Clinical Laboratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
– sequence: 4
  givenname: Ming
  surname: Chen
  fullname: Chen, Ming
  email: chming1971@126.com
  organization: Department of Clinical Laboratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
– sequence: 5
  givenname: Ji
  surname: Zheng
  fullname: Zheng, Ji
  email: jizheng023@aliyun.com
  organization: Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Army Medical University (Third Military Medical University), Chongqing, 400037, PR China
– sequence: 6
  givenname: Kai
  surname: Chang
  fullname: Chang, Kai
  email: changkai0203@tmmu.edu.cn
  organization: Department of Clinical Laboratory Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, PR China
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39247145$$D View this record in MEDLINE/PubMed
BookMark eNp9kc1rFTEUxQep2Fr7FwiSpZsZbz5mkhFclIfWQlUQXbkI-bhT8pyXPJN5Rf_7pu-1Ii66SgjnnHvzO8-bo5giNs1LCh0FOrxZd9HlaDoGTHQgOwD-pDlhYlAt9AKO_rkfN2elrAGAKjYMg3jWHPORCUlFf9L8WO1yxriQ2URfnNkiSRPB36mkjZlJndq65EO8Jl8_nxcSItnmVBazIHEmOsxvyafkd7NZUi6kZhAbqjP_xFxeNE8nMxc8uz9Pm-8f3n9bfWyvvlxcrs6vWickLK3spWRUqJEO3oG0MIFzjllLrRi5mtRkGWUD805wpgYcvZBoOeu9scYpwU-by0OuT2attznU-X90MkHvH1K-1iYvwc2op0FAL9VomLfCMKPGmq0qQ-EceOA16_Uhq37z1w7LojehOJwrHky7ojkFBpJx3lfpq3vpzm7Q_x38ALcKxoPAVWQl46RdqORCiks2YdYU9F2Xeq33Xeq7LjVIDfs9-H_eh_jHXe8OLqy4bwJmXVzAWpMPGd1SeYRH_bfSn7e7
CitedBy_id crossref_primary_10_3390_cancers17060940
crossref_primary_10_3390_biomedicines12102322
crossref_primary_10_1093_biolre_ioae170
crossref_primary_10_1155_sci_8883585
Cites_doi 10.1002/pros.23376
10.1158/0008-5472.CAN-12-2968
10.3390/ijms221810107
10.1159/000488620
10.1371/journal.pone.0055527
10.1016/j.stem.2010.11.013
10.1371/journal.pone.0157566
10.1038/s41556-018-0040-4
10.3389/fcell.2021.644397
10.1172/JCI86505
10.1186/1471-2407-7-64
10.1080/21655979.2022.2037367
10.1016/S1534-5807(04)00075-9
10.1016/j.bbagrm.2014.02.016
10.3389/fonc.2018.00222
10.1038/nrurol.2017.144
10.3390/cancers11091276
10.1155/2022/8058770
10.1186/s12943-018-0831-z
10.1073/pnas.1717363115
10.1186/s12951-022-01264-5
10.1002/jcp.29784
10.1038/nrc.2017.99
10.1261/rna.035667.112
10.1002/ctm2.493
10.1038/s41392-020-00359-5
10.1016/j.mam.2017.11.010
10.1186/s12935-020-01563-7
10.1016/j.cell.2019.10.017
10.1002/pros.23101
10.1186/s13046-020-01761-1
10.1177/09636897211052977
10.1093/nar/gkr828
10.1002/pros.24029
10.3892/ijo.2015.3043
10.4149/neo_2020_191130N1234
10.1161/CIRCRESAHA.117.305990
10.1002/pros.22848
10.1210/endrev/bnab002
10.3322/caac.21708
10.1038/onc.2017.240
10.1371/journal.pone.0019139
10.1038/ncomms11150
10.1002/stem.1619
10.1158/2159-8290.CD-21-1059
10.1038/nature09677
10.1016/j.bbcan.2019.04.004
10.1080/21655979.2021.2009416
10.1038/s42003-020-01642-5
10.1016/j.bios.2015.09.053
10.3727/096504017X14882829077237
10.1186/s13046-019-1488-1
10.1158/0008-5472.CAN-09-1448
10.1002/ctm2.426
10.1038/bjc.2011.595
10.1038/mt.2012.180
10.1016/j.biopha.2019.109109
10.1016/j.devcel.2021.03.020
10.1161/CIRCULATIONAHA.120.045765
10.3390/biom11121829
10.1016/j.bbrc.2018.05.157
10.1038/s41585-022-00622-0
10.1016/j.canlet.2017.09.010
10.1016/j.jconrel.2022.01.026
10.1016/j.ymthe.2019.09.001
10.1038/onc.2013.7
10.1016/S0092-8674(00)81683-9
10.1074/jbc.M203569200
10.3390/ijms23031626
10.1038/s41585-021-00524-7
10.1038/srep24922
10.1016/j.bbrc.2019.05.120
10.1016/j.bios.2019.111749
10.1002/pros.20870
10.1158/1078-0432.CCR-15-3107
10.1007/s10528-021-10160-w
10.1016/j.jbiotec.2017.07.029
10.3390/ijms21165840
10.3122/jabfm.16.2.95
10.3390/genes11121495
10.3390/cancers13164075
10.1186/s13046-014-0072-y
10.1016/j.ab.2021.114336
10.1186/s12943-018-0897-7
10.1158/0008-5472.CAN-10-1791
10.3389/fcell.2020.599494
10.1155/2022/7616696
10.1126/science.aau6977
10.1080/15384101.2015.1041689
10.1007/s12195-016-0457-4
10.1038/s41467-017-01196-x
10.1371/journal.pone.0159490
10.1038/cddis.2010.85
10.1158/0008-5472.CAN-14-0404
10.1016/j.eururo.2014.07.035
10.1016/j.bbalip.2013.04.011
10.1158/0008-5472.CAN-17-2069
10.1002/jgm.3376
10.1371/journal.pone.0051655
10.18632/oncotarget.22014
10.1002/jcp.28374
10.3390/ijms23031285
10.1016/j.bbrc.2009.03.077
10.1074/jbc.C114.617662
10.3390/pharmaceutics12060545
10.3390/genes8020071
10.3390/ijms17111784
10.4149/neo_2018_180427N279
10.1242/dev.095448
10.1186/s13046-021-01843-8
10.1111/j.1742-4658.2008.06697.x
10.1146/annurev-pathol-020117-043854
10.1007/s13277-014-2006-x
10.1080/15384101.2021.1992853
10.1007/s12038-021-00190-2
10.18632/oncotarget.5920
10.1177/1533033820972342
10.1016/j.critrevonc.2019.102860
10.1016/j.cellsig.2021.110126
10.1161/ATVBAHA.111.243733
10.1186/s12943-017-0742-4
10.1038/s12276-020-0431-z
10.1002/cncr.32176
10.1038/srep43500
10.1038/s41598-018-26050-y
10.1186/s13046-017-0528-y
10.18632/aging.103377
10.1186/s12885-017-3737-z
10.1038/nrc3792
10.1016/j.bios.2021.113504
10.1186/s12943-019-1002-6
10.1111/cyt.12661
10.1186/s13048-020-0609-y
10.1038/s12276-018-0150-x
10.1007/s11306-019-1550-1
10.1158/1541-7786.MCR-17-0321
10.1002/jcb.28239
10.1080/14728222.2017.1369044
10.1016/j.prp.2020.153182
10.1016/S0140-6736(18)31694-5
10.1038/s41598-018-27180-z
10.1038/cdd.2014.232
10.1007/s00604-020-4143-9
10.2147/OTT.S272869
10.1186/1476-4598-9-258
10.1038/s41585-021-00561-2
10.1186/s13045-019-0739-0
10.1002/advs.202003505
10.1186/s12943-020-01235-0
10.1038/s41585-022-00638-6
10.1016/j.neo.2018.01.011
10.1016/j.cell.2011.02.013
10.3390/ijms23116339
10.1172/JCI65344
10.1007/978-3-319-95693-0_6
10.1002/jev2.12056
10.7150/thno.44567
10.1038/s41419-020-2671-1
10.1002/pros.23295
10.1186/1471-2407-11-31
10.1038/s41598-020-62140-6
10.1038/s41585-022-00588-z
10.1038/cdd.2014.213
10.1186/1478-811X-11-88
10.1016/S0140-6736(18)32279-7
10.1186/s12943-019-0991-5
10.1016/S0140-6736(21)00950-8
10.1370/afm.2205
10.1002/jcp.21241
10.1126/sciadv.aba5714
10.1038/cr.2015.82
10.1097/CM9.0000000000002108
10.1038/s41419-021-04421-0
10.18632/oncotarget.1884
10.1038/aps.2017.178
10.1186/s12943-017-0726-4
10.1186/s12935-020-01686-x
10.3892/ijo.2020.5064
10.2147/DDDT.S300376
10.1021/acsomega.4c02652
10.1186/s12943-019-1041-z
10.2147/CMAR.S272140
10.1186/s12943-021-01396-6
ContentType Journal Article
Copyright 2024 The Authors
2024 The Authors.
Copyright_xml – notice: 2024 The Authors
– notice: 2024 The Authors.
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
DOA
DOI 10.1016/j.ncrna.2024.07.003
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 2468-0540
EndPage 1362
ExternalDocumentID oai_doaj_org_article_f6405789a2db4a2a89b2180244cc0d03
39247145
10_1016_j_ncrna_2024_07_003
S2468054024001239
Genre Journal Article
Review
GroupedDBID 0R~
0SF
53G
6I.
AACTN
AAEDW
AAFTH
AALRI
AAXUO
ABMAC
ACGFS
ADBBV
ADVLN
AEXQZ
AFTJW
AITUG
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
NCXOZ
OK1
ROL
RPM
SSZ
AAYWO
AAYXX
CITATION
NPM
7X8
ID FETCH-LOGICAL-c470t-75772148916dc07b0f0ccc2bb1b4938f8fb21262dc43286e9d47eb325dabac843
IEDL.DBID DOA
ISSN 2468-0540
IngestDate Wed Aug 27 01:27:17 EDT 2025
Fri Jul 11 00:25:43 EDT 2025
Mon Jul 21 06:04:54 EDT 2025
Tue Jul 01 02:39:37 EDT 2025
Thu Apr 24 22:51:42 EDT 2025
Sat Dec 21 16:00:41 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Biomarkers
Non-coding RNAs
Exosomes
Prostate cancer
Modulators
Language English
License This is an open access article under the CC BY-NC-ND license.
2024 The Authors.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c470t-75772148916dc07b0f0ccc2bb1b4938f8fb21262dc43286e9d47eb325dabac843
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://doaj.org/article/f6405789a2db4a2a89b2180244cc0d03
PMID 39247145
PQID 3102072335
PQPubID 23479
PageCount 12
ParticipantIDs doaj_primary_oai_doaj_org_article_f6405789a2db4a2a89b2180244cc0d03
proquest_miscellaneous_3102072335
pubmed_primary_39247145
crossref_citationtrail_10_1016_j_ncrna_2024_07_003
crossref_primary_10_1016_j_ncrna_2024_07_003
elsevier_sciencedirect_doi_10_1016_j_ncrna_2024_07_003
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate December 2024
2024-12-00
2024-Dec
20241201
2024-12-01
PublicationDateYYYYMMDD 2024-12-01
PublicationDate_xml – month: 12
  year: 2024
  text: December 2024
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle Non-coding RNA research
PublicationTitleAlternate Noncoding RNA Res
PublicationYear 2024
Publisher Elsevier B.V
KeAi Communications Co., Ltd
Publisher_xml – name: Elsevier B.V
– name: KeAi Communications Co., Ltd
References Chen, Lai, Jan (bib56) 2013; 123
Wei, Batagov, Schinelli (bib37) 2017; 8
Zhou, Chen, He, Zheng, Xue (bib70) 2020; 13
Endzelins, Berger, Melne (bib53) 2017; 17
Ali, Du Feu, Oliveira (bib18) 2022; 19
Sulzmaier, Jean, Schlaepfer (bib73) 2014; 14
Tian, Liang, Shi, Zhao (bib140) 2022; 2022
He, Zhang, Han (bib126) 2014; 33
Hanahan (bib43) 2022; 12
Arroyo A, Salloum-Asfar, Perez-Sanchez (bib49) 2017; 7
Tang, Liu, Wang (bib133) 2019; 42
Li, He, Guo (bib196) 2022; 20
Yu, Sui, Fan (bib119) 2021; 10
Ghosh, Pandey, Dey (bib167) 2019; 30
Wang, Liu, Ma (bib17) 2019; 18
Peck, Oberst, Bouker, Bowden, Burbelo (bib75) 2002; 277
Li, Dong, Wang (bib175) 2020; 67
Zhang, Zhao, Ding (bib94) 2020; 39
Guan, Peng, Fang (bib77) 2020; 235
Albino, Falcione, Uboldi (bib104) 2021; 4
Wang, Xiao, Pan, Chen, Yang (bib66) 2022; 2022
Zhang, Freitas, Kim (bib33) 2018; 20
Kim, Shim, Han (bib188) 2021; 192
Huang, Wu, Jing (bib197) 2022; 343
Li, Li, Sha, Sun, Huang (bib67) 2009; 383
Rebello, Pearson, Hannan, Furic (bib136) 2017; 8
Abd Elmageed, Yang, Thomas (bib101) 2014; 32
Yang, Wang, Gong (bib84) 2020; 5
Khan, Nickoloff, Abramova (bib191) 2015; 117
Thomsen, Bakiri, Hasenfuss (bib78) 2015; 22
Bryzgunova, Zaripov, Skvortsova (bib172) 2016; 11
Li, Ma, Wang (bib176) 2016; 9
Ribas, Ni, Haffner (bib124) 2009; 69
Yang, Han, Zhang (bib198) 2020; 142
Guo, Wang, Jia (bib183) 2020; 8
Hanahan, Weinberg (bib44) 2011; 144
Ge, Yu, Li (bib137) 2021; 40
Li, Li, Diao (bib171) 2021; 13
Lang, Yin, Lin (bib62) 2021; 11
Tonini, D'Andrilli, Fucito, Gaspa, Bagella (bib89) 2008; 214
Ding, Wu, Chu (bib92) 2011; 470
Ye, Li, Ma (bib108) 2017; 8
Shtam, Kovalev, Varfolomeeva (bib193) 2013; 11
Su, Xiao, Ma (bib39) 2019; 18
Aslan, Maralbashi, Salari (bib46) 2019; 234
Bhagirath, Yang, Bucay (bib98) 2018; 78
Pulliam, Goli, Awad (bib3) 2022; 19
Rodriguez, Bajo-Santos, Hessvik (bib170) 2017; 16
Hasegawa, Glavich, Pahuski (bib88) 2018; 16
Bryant, Pawlowski, Catto (bib177) 2012; 106
Lamichhane, Jeyaram, Patel (bib194) 2016; 9
Mistry, Cable (bib10) 2003; 16
Chandran, Ma, Dhir (bib146) 2007; 7
Zhang, Yu (bib11) 2019; 1871
Li, Tang, Deng (bib169) 2024; 9
Zhang, Li, Han (bib68) 2019; 66
Shang, Gu, Wang (bib58) 2020; 19
Kato, Goto, Matsushita (bib100) 2015; 47
Graham, Odero-Marah, Chung (bib118) 2009; 69
Clay, Halloran (bib115) 2013; 140
Jiang, Mo, Guo (bib74) 2019; 38
Wang, Yang, Li (bib135) 2018; 40
Guo, Lu, Yang (bib148) 2022; 2022
Ramalinga, Roy, Srivastava (bib151) 2015; 6
Ohno, Takanashi, Sudo (bib195) 2013; 21
Au Yeung, Co, Tsuruga (bib60) 2016; 7
Zhang, Liang, Yue (bib95) 2020; 57
Arenas-Gallo, Owiredu, Weinstein (bib5) 2022; 19
Tang, Wang, Zhou (bib13) 2020; 187
Pinsky, Black, Daugherty (bib9) 2019; 125
Jiang, Zhang, Liu, Gu, Wu (bib69) 2017; 25
Foreman, Marquez, Dolgert (bib4) 2018; 392
Peraldo-Neia, Migliardi, Mello-Grand (bib96) 2011; 11
Mezzasoma, Costanzi, Scarpelli, Talesa, Bellezza (bib106) 2019; 11
Jeong, Jin, Park (bib91) 2012; 40
Byrne, Frost, Chen, Bright (bib162) 2014; 35
Liu, Gong, Sun, Li (bib144) 2014; 1839
Isin, Uysaler, Ozgur (bib181) 2015; 6
Teng, Fussenegger (bib20) 2020; 8
Wang, Wang, Zhu (bib99) 2019; 117
Rodriguez-Nieves, Patalano, Almanza, Gharaee-Kermani, Macoska (bib120) 2016; 11
Li, Zhang, Xiang (bib132) 2020; 10
Mo, Huang, Zhuang (bib145) 2021; 11
Zhang, He, Xue (bib164) 2011; 71
Sun, Yang, Zhou (bib16) 2018; 17
Huang, Yuan, Liang (bib184) 2015; 67
Tao, Zhou, Yuan (bib32) 2019; 15
Rong, Xu, Hu (bib107) 2020; 20
Lei, Liang, Wang, Liu, Wang (bib111) 2019; 23
Cho, Yang, Rhee (bib189) 2019; 146
Costanzi, Romani, Scarpelli, Bellezza (bib55) 2020; 11
Jin, Zhang, Liu (bib159) 2014; 74
Cheng, Zhang, Qing (bib31) 2020; 13
Xia, Dong, Li (bib2) 2022; 135
Coradduzza, Cruciani, Arru (bib125) 2022; 23
Ahadi, Brennan, Kennedy, Hutvagner, Tran (bib180) 2016; 6
Odero-Marah, Hawsawi, Henderson, Sweeney (bib158) 2018; 1095
Vlaeminck-Guillem (bib24) 2018; 8
Li, Zheng, Bao (bib41) 2015; 25
Wang, Ji, Wang (bib179) 2018; 46
Yamayoshi, Oyama, Kishimoto (bib199) 2020; 12
Fedele, Singh, Zerlanko, Iozzo, Languino (bib25) 2015; 290
Wa, Li, Lin (bib93) 2018; 39
Liu, Zhang, Jiang (bib80) 2017; 16
Bhatnagar, Li, Padi (bib123) 2010; 1
Konoshenko, Bryzgunova, Laktionov (bib166) 2021; 1876
Zhang, Chen, Wang, Ahmad, Liu (bib72) 2015; 14
Ma, Bai, Zhang (bib86) 2020; 11
Li, Ji, Lyu (bib178) 2021; 13
Sun, Shi, Yang (bib15) 2018; 17
Thakur, Parra, Motallebnejad, Brocchi, Chen (bib21) 2022
Birner, Egger, Merkel, Kenner (bib79) 2015; 22
Pascal, Wang, Zhong (bib129) 2018; 20
Jiang, Chen, He, Wang (bib61) 2022; 13
Filella, Foj (bib12) 2016; 17
Dai, Gao (bib65) 2021; 21
Kalluri, LeBleu (bib22) 2020; 367
Foj, Ferrer, Serra (bib51) 2017; 77
Lin, Chiu, Banerjee (bib122) 2013; 73
Vinik, Ortega, Mills (bib28) 2020; 6
Shan, Gu, Zhou (bib130) 2020; 52
Ding, Zhu, Jin (bib138) 2021; 9
Tang, Liu, Li, Wang (bib150) 2021; 46
Li, An, Liu (bib110) 2019; 17
Xu, Qin, An (bib173) 2017; 77
Zhu, Zhang, Hu (bib57) 2020; 10
Wang, Su, Zhong (bib185) 2020; 8
Naji, Randhawa, Sohani (bib168) 2018; 16
Li, Lin, Jiang, Yu (bib192) 2018; 39
Sung, Parent, Weaver (bib82) 2021; 56
Zhang, Li, Zhang, Shen, Gui (bib161) 2021; 15
Sandhu, Moore, Chiong (bib7) 2021; 398
Jeck, Sorrentino, Wang (bib40) 2013; 19
Corcoran, Rani, O'Driscoll (bib131) 2014; 74
Wu, Woo, Seo, Kwon (bib156) 2021; 22
Zhang, Liu, Yang, Wang, Xing (bib157) 2022; 24
Tripathi, Popescu, Zimonjic (bib109) 2014; 33
Desai, McManus, Sharifi (bib147) 2021; 42
Pardo, Villalobos-Labra, Sobrevia, Toledo, Sobrevia (bib83) 2018; 60
Nan, Wang, Yang, Chen (bib87) 2020; 216
Hashimoto, Ochi, Sunamura (bib113) 2018; 115
Wang, Ni, Beretov (bib14) 2020; 145
Liao, Chen, Li (bib155) 2021; 20
Dallavalle, Albino, Civenni (bib105) 2016; 126
Zou, Dai, Deng, Su, Liu (bib116) 2021; 30
Disease (bib8) 2018; 392
Brzozowski, Bond, Jankowski (bib26) 2018; 8
Baniwal, Khalid, Gabet (bib112) 2010; 9
Slack, Chinnaiyan (bib38) 2019; 179
Mashouri, Yousefi, Aref (bib27) 2019; 18
Cao, Xu, Zhao (bib127) 2019; 515
Tang, Guo, Gao (bib42) 2021; 20
Lukacs, Memarzadeh, Wu, Witte (bib152) 2010; 7
Rowena, Pirone, Nelson, Bhadriraju, Chen (bib114) 2004; 6
Yang, Liu, Liu, Cao (bib165) 2021; 9
Ummanni, Teller, Junker (bib163) 2008; 275
Wei, Zhou, Li (bib186) 2016; 77
Bansal, Bartucci, Yusuff (bib160) 2016; 22
Bullock, Silva, Kanlikilicer-Unaldi (bib36) 2015; 1
Samsonov, Shtam, Burdakov (bib52) 2016; 76
Murillo-Garzon, Kypta (bib149) 2017; 14
Liu, Li, Chen (bib54) 2011; 6
Furesi, de Jesus Domingues, Alexopoulou (bib117) 2022; 23
Ding, Wang, Yang (bib63) 2022; 13
Chen, Wang, Xu (bib142) 2020; 10
Wang, Chen, Shi (bib90) 2020; 80
Wani, Kaul, Mavuduru, Kakkar, Bhatia (bib174) 2017; 259
Llorente, Skotland, Sylvanne (bib29) 2013; 1831
Jiang, Song, Wu (bib153) 2013; 8
Holroyd, Delacroix, Larsen (bib50) 2012; 32
Luo, Zhao, Cheng (bib30) 2018; 50
Van Poppel, Albreht, Basu (bib6) 2022; 19
Mittal (bib97) 2018; 13
Chappell, Candido, Abrams (bib128) 2020; 12
Li, Hu, Shi (bib139) 2021; 20
Hu, Afradiasbagharani, Lu (bib76) 2021; 11
Li, Sun, Chen (bib154) 2020; 121
Hanahan, Weinberg (bib45) 2000; 100
Wang, Liu, Zeng (bib187) 2021; 630
Wu (bib182) 2022; 60
Zheng, Chen, Yuan (bib59) 2017; 36
Lin, Nikolic, Yang (bib71) 2018; 8
Guo, Cui, Ji (bib102) 2017; 36
Heidegger, Kern, Ofer, Klocker, Massoner (bib64) 2014; 5
Bertoli, Panio, Cava (bib85) 2022; 23
El-Sayed, Daher, Destouches (bib121) 2017; 410
Prigol, Rode, Silva, Cisilotto, Creczynski-Pasa (bib48) 2021; 87
Siegel, Miller, Fuchs, Jemal (bib1) 2022; 72
Wang, Zhu, Meng (bib34) 2019; 27
Jiang, Zhao, Chen (bib143) 2021; 12
Baures, Dariane, Tika (bib19) 2022; 19
Xiao, Cheng, Chiang (bib190) 2016; 6
Mathivanan, Fahner, Reid, Simpson (bib23) 2012; 40
Anastasiadou, Jacob, Slack (bib35) 2018; 18
Olejarz, Kubiak-Tomaszewska, Chrzanowska, Lorenc (bib47) 2020; 21
Kim, Lee, Shin (bib134) 2017; 21
Yang, Wang, Li (bib141) 2018; 502
Sheth, Jajoo, Kaur (bib103) 2012; 7
Wu, Zhou, Lv, Zhu, Tang (bib81) 2019; 12
Jiang (10.1016/j.ncrna.2024.07.003_bib61) 2022; 13
Liao (10.1016/j.ncrna.2024.07.003_bib155) 2021; 20
Lukacs (10.1016/j.ncrna.2024.07.003_bib152) 2010; 7
Li (10.1016/j.ncrna.2024.07.003_bib154) 2020; 121
Graham (10.1016/j.ncrna.2024.07.003_bib118) 2009; 69
Jiang (10.1016/j.ncrna.2024.07.003_bib153) 2013; 8
Xiao (10.1016/j.ncrna.2024.07.003_bib190) 2016; 6
Desai (10.1016/j.ncrna.2024.07.003_bib147) 2021; 42
Ahadi (10.1016/j.ncrna.2024.07.003_bib180) 2016; 6
Bullock (10.1016/j.ncrna.2024.07.003_bib36) 2015; 1
Hanahan (10.1016/j.ncrna.2024.07.003_bib44) 2011; 144
Shang (10.1016/j.ncrna.2024.07.003_bib58) 2020; 19
Chen (10.1016/j.ncrna.2024.07.003_bib142) 2020; 10
Lei (10.1016/j.ncrna.2024.07.003_bib111) 2019; 23
Olejarz (10.1016/j.ncrna.2024.07.003_bib47) 2020; 21
Costanzi (10.1016/j.ncrna.2024.07.003_bib55) 2020; 11
Hanahan (10.1016/j.ncrna.2024.07.003_bib45) 2000; 100
Bhatnagar (10.1016/j.ncrna.2024.07.003_bib123) 2010; 1
Furesi (10.1016/j.ncrna.2024.07.003_bib117) 2022; 23
Li (10.1016/j.ncrna.2024.07.003_bib169) 2024; 9
Jin (10.1016/j.ncrna.2024.07.003_bib159) 2014; 74
Holroyd (10.1016/j.ncrna.2024.07.003_bib50) 2012; 32
Sulzmaier (10.1016/j.ncrna.2024.07.003_bib73) 2014; 14
Albino (10.1016/j.ncrna.2024.07.003_bib104) 2021; 4
Ribas (10.1016/j.ncrna.2024.07.003_bib124) 2009; 69
Li (10.1016/j.ncrna.2024.07.003_bib196) 2022; 20
Li (10.1016/j.ncrna.2024.07.003_bib139) 2021; 20
Ali (10.1016/j.ncrna.2024.07.003_bib18) 2022; 19
Shan (10.1016/j.ncrna.2024.07.003_bib130) 2020; 52
Guo (10.1016/j.ncrna.2024.07.003_bib148) 2022; 2022
Zhang (10.1016/j.ncrna.2024.07.003_bib68) 2019; 66
Aslan (10.1016/j.ncrna.2024.07.003_bib46) 2019; 234
Disease (10.1016/j.ncrna.2024.07.003_bib8) 2018; 392
Lamichhane (10.1016/j.ncrna.2024.07.003_bib194) 2016; 9
Mittal (10.1016/j.ncrna.2024.07.003_bib97) 2018; 13
Au Yeung (10.1016/j.ncrna.2024.07.003_bib60) 2016; 7
Thakur (10.1016/j.ncrna.2024.07.003_bib21) 2022
Liu (10.1016/j.ncrna.2024.07.003_bib144) 2014; 1839
Bansal (10.1016/j.ncrna.2024.07.003_bib160) 2016; 22
Bertoli (10.1016/j.ncrna.2024.07.003_bib85) 2022; 23
Birner (10.1016/j.ncrna.2024.07.003_bib79) 2015; 22
Li (10.1016/j.ncrna.2024.07.003_bib175) 2020; 67
Wang (10.1016/j.ncrna.2024.07.003_bib34) 2019; 27
Yang (10.1016/j.ncrna.2024.07.003_bib198) 2020; 142
Peraldo-Neia (10.1016/j.ncrna.2024.07.003_bib96) 2011; 11
Slack (10.1016/j.ncrna.2024.07.003_bib38) 2019; 179
Ramalinga (10.1016/j.ncrna.2024.07.003_bib151) 2015; 6
Xu (10.1016/j.ncrna.2024.07.003_bib173) 2017; 77
Xia (10.1016/j.ncrna.2024.07.003_bib2) 2022; 135
Samsonov (10.1016/j.ncrna.2024.07.003_bib52) 2016; 76
Mistry (10.1016/j.ncrna.2024.07.003_bib10) 2003; 16
Van Poppel (10.1016/j.ncrna.2024.07.003_bib6) 2022; 19
Arenas-Gallo (10.1016/j.ncrna.2024.07.003_bib5) 2022; 19
Liu (10.1016/j.ncrna.2024.07.003_bib54) 2011; 6
Luo (10.1016/j.ncrna.2024.07.003_bib30) 2018; 50
Tripathi (10.1016/j.ncrna.2024.07.003_bib109) 2014; 33
Wang (10.1016/j.ncrna.2024.07.003_bib14) 2020; 145
Abd Elmageed (10.1016/j.ncrna.2024.07.003_bib101) 2014; 32
Zhang (10.1016/j.ncrna.2024.07.003_bib164) 2011; 71
Guo (10.1016/j.ncrna.2024.07.003_bib183) 2020; 8
Naji (10.1016/j.ncrna.2024.07.003_bib168) 2018; 16
El-Sayed (10.1016/j.ncrna.2024.07.003_bib121) 2017; 410
Tian (10.1016/j.ncrna.2024.07.003_bib140) 2022; 2022
Wang (10.1016/j.ncrna.2024.07.003_bib17) 2019; 18
Corcoran (10.1016/j.ncrna.2024.07.003_bib131) 2014; 74
Sun (10.1016/j.ncrna.2024.07.003_bib15) 2018; 17
Mathivanan (10.1016/j.ncrna.2024.07.003_bib23) 2012; 40
Rowena (10.1016/j.ncrna.2024.07.003_bib114) 2004; 6
Foj (10.1016/j.ncrna.2024.07.003_bib51) 2017; 77
Li (10.1016/j.ncrna.2024.07.003_bib178) 2021; 13
Tang (10.1016/j.ncrna.2024.07.003_bib150) 2021; 46
Wu (10.1016/j.ncrna.2024.07.003_bib81) 2019; 12
Vlaeminck-Guillem (10.1016/j.ncrna.2024.07.003_bib24) 2018; 8
Heidegger (10.1016/j.ncrna.2024.07.003_bib64) 2014; 5
Wang (10.1016/j.ncrna.2024.07.003_bib135) 2018; 40
Foreman (10.1016/j.ncrna.2024.07.003_bib4) 2018; 392
Prigol (10.1016/j.ncrna.2024.07.003_bib48) 2021; 87
Wang (10.1016/j.ncrna.2024.07.003_bib99) 2019; 117
Pardo (10.1016/j.ncrna.2024.07.003_bib83) 2018; 60
Mo (10.1016/j.ncrna.2024.07.003_bib145) 2021; 11
Wang (10.1016/j.ncrna.2024.07.003_bib187) 2021; 630
Kato (10.1016/j.ncrna.2024.07.003_bib100) 2015; 47
Wei (10.1016/j.ncrna.2024.07.003_bib186) 2016; 77
Rong (10.1016/j.ncrna.2024.07.003_bib107) 2020; 20
Yu (10.1016/j.ncrna.2024.07.003_bib119) 2021; 10
Rodriguez-Nieves (10.1016/j.ncrna.2024.07.003_bib120) 2016; 11
Ummanni (10.1016/j.ncrna.2024.07.003_bib163) 2008; 275
Guan (10.1016/j.ncrna.2024.07.003_bib77) 2020; 235
Huang (10.1016/j.ncrna.2024.07.003_bib184) 2015; 67
Zhu (10.1016/j.ncrna.2024.07.003_bib57) 2020; 10
Yang (10.1016/j.ncrna.2024.07.003_bib141) 2018; 502
Nan (10.1016/j.ncrna.2024.07.003_bib87) 2020; 216
Wani (10.1016/j.ncrna.2024.07.003_bib174) 2017; 259
Odero-Marah (10.1016/j.ncrna.2024.07.003_bib158) 2018; 1095
Wu (10.1016/j.ncrna.2024.07.003_bib156) 2021; 22
Sandhu (10.1016/j.ncrna.2024.07.003_bib7) 2021; 398
Clay (10.1016/j.ncrna.2024.07.003_bib115) 2013; 140
Rebello (10.1016/j.ncrna.2024.07.003_bib136) 2017; 8
Tonini (10.1016/j.ncrna.2024.07.003_bib89) 2008; 214
Zhang (10.1016/j.ncrna.2024.07.003_bib161) 2021; 15
Ge (10.1016/j.ncrna.2024.07.003_bib137) 2021; 40
Zheng (10.1016/j.ncrna.2024.07.003_bib59) 2017; 36
Yang (10.1016/j.ncrna.2024.07.003_bib84) 2020; 5
Brzozowski (10.1016/j.ncrna.2024.07.003_bib26) 2018; 8
Sheth (10.1016/j.ncrna.2024.07.003_bib103) 2012; 7
Dai (10.1016/j.ncrna.2024.07.003_bib65) 2021; 21
Hashimoto (10.1016/j.ncrna.2024.07.003_bib113) 2018; 115
Hanahan (10.1016/j.ncrna.2024.07.003_bib43) 2022; 12
Cao (10.1016/j.ncrna.2024.07.003_bib127) 2019; 515
Peck (10.1016/j.ncrna.2024.07.003_bib75) 2002; 277
Mezzasoma (10.1016/j.ncrna.2024.07.003_bib106) 2019; 11
Llorente (10.1016/j.ncrna.2024.07.003_bib29) 2013; 1831
Kim (10.1016/j.ncrna.2024.07.003_bib134) 2017; 21
Ye (10.1016/j.ncrna.2024.07.003_bib108) 2017; 8
Guo (10.1016/j.ncrna.2024.07.003_bib102) 2017; 36
Wei (10.1016/j.ncrna.2024.07.003_bib37) 2017; 8
Rodriguez (10.1016/j.ncrna.2024.07.003_bib170) 2017; 16
Lin (10.1016/j.ncrna.2024.07.003_bib71) 2018; 8
Lang (10.1016/j.ncrna.2024.07.003_bib62) 2021; 11
Tang (10.1016/j.ncrna.2024.07.003_bib13) 2020; 187
Bryant (10.1016/j.ncrna.2024.07.003_bib177) 2012; 106
Ghosh (10.1016/j.ncrna.2024.07.003_bib167) 2019; 30
Tao (10.1016/j.ncrna.2024.07.003_bib32) 2019; 15
Jiang (10.1016/j.ncrna.2024.07.003_bib74) 2019; 38
Sun (10.1016/j.ncrna.2024.07.003_bib16) 2018; 17
Pascal (10.1016/j.ncrna.2024.07.003_bib129) 2018; 20
Arroyo A (10.1016/j.ncrna.2024.07.003_bib49) 2017; 7
He (10.1016/j.ncrna.2024.07.003_bib126) 2014; 33
Wang (10.1016/j.ncrna.2024.07.003_bib90) 2020; 80
Huang (10.1016/j.ncrna.2024.07.003_bib197) 2022; 343
Jiang (10.1016/j.ncrna.2024.07.003_bib69) 2017; 25
Murillo-Garzon (10.1016/j.ncrna.2024.07.003_bib149) 2017; 14
Baures (10.1016/j.ncrna.2024.07.003_bib19) 2022; 19
Li (10.1016/j.ncrna.2024.07.003_bib132) 2020; 10
Kalluri (10.1016/j.ncrna.2024.07.003_bib22) 2020; 367
Ding (10.1016/j.ncrna.2024.07.003_bib92) 2011; 470
Ding (10.1016/j.ncrna.2024.07.003_bib63) 2022; 13
Tang (10.1016/j.ncrna.2024.07.003_bib42) 2021; 20
Jeck (10.1016/j.ncrna.2024.07.003_bib40) 2013; 19
Ohno (10.1016/j.ncrna.2024.07.003_bib195) 2013; 21
Zou (10.1016/j.ncrna.2024.07.003_bib116) 2021; 30
Cho (10.1016/j.ncrna.2024.07.003_bib189) 2019; 146
Dallavalle (10.1016/j.ncrna.2024.07.003_bib105) 2016; 126
Chandran (10.1016/j.ncrna.2024.07.003_bib146) 2007; 7
Lin (10.1016/j.ncrna.2024.07.003_bib122) 2013; 73
Li (10.1016/j.ncrna.2024.07.003_bib41) 2015; 25
Mashouri (10.1016/j.ncrna.2024.07.003_bib27) 2019; 18
Jiang (10.1016/j.ncrna.2024.07.003_bib143) 2021; 12
Hu (10.1016/j.ncrna.2024.07.003_bib76) 2021; 11
Zhang (10.1016/j.ncrna.2024.07.003_bib33) 2018; 20
Li (10.1016/j.ncrna.2024.07.003_bib110) 2019; 17
Wang (10.1016/j.ncrna.2024.07.003_bib179) 2018; 46
Vinik (10.1016/j.ncrna.2024.07.003_bib28) 2020; 6
Baniwal (10.1016/j.ncrna.2024.07.003_bib112) 2010; 9
Konoshenko (10.1016/j.ncrna.2024.07.003_bib166) 2021; 1876
Wang (10.1016/j.ncrna.2024.07.003_bib66) 2022; 2022
Wu (10.1016/j.ncrna.2024.07.003_bib182) 2022; 60
Liu (10.1016/j.ncrna.2024.07.003_bib80) 2017; 16
Ding (10.1016/j.ncrna.2024.07.003_bib138) 2021; 9
Li (10.1016/j.ncrna.2024.07.003_bib176) 2016; 9
Pulliam (10.1016/j.ncrna.2024.07.003_bib3) 2022; 19
Zhou (10.1016/j.ncrna.2024.07.003_bib70) 2020; 13
Bryzgunova (10.1016/j.ncrna.2024.07.003_bib172) 2016; 11
Endzelins (10.1016/j.ncrna.2024.07.003_bib53) 2017; 17
Li (10.1016/j.ncrna.2024.07.003_bib192) 2018; 39
Wa (10.1016/j.ncrna.2024.07.003_bib93) 2018; 39
Yamayoshi (10.1016/j.ncrna.2024.07.003_bib199) 2020; 12
Chappell (10.1016/j.ncrna.2024.07.003_bib128) 2020; 12
Byrne (10.1016/j.ncrna.2024.07.003_bib162) 2014; 35
Filella (10.1016/j.ncrna.2024.07.003_bib12) 2016; 17
Li (10.1016/j.ncrna.2024.07.003_bib67) 2009; 383
Ma (10.1016/j.ncrna.2024.07.003_bib86) 2020; 11
Su (10.1016/j.ncrna.2024.07.003_bib39) 2019; 18
Tang (10.1016/j.ncrna.2024.07.003_bib133) 2019; 42
Hasegawa (10.1016/j.ncrna.2024.07.003_bib88) 2018; 16
Li (10.1016/j.ncrna.2024.07.003_bib171) 2021; 13
Thomsen (10.1016/j.ncrna.2024.07.003_bib78) 2015; 22
Chen (10.1016/j.ncrna.2024.07.003_bib56) 2013; 123
Zhang (10.1016/j.ncrna.2024.07.003_bib11) 2019; 1871
Khan (10.1016/j.ncrna.2024.07.003_bib191) 2015; 117
Shtam (10.1016/j.ncrna.2024.07.003_bib193) 2013; 11
Fedele (10.1016/j.ncrna.2024.07.003_bib25) 2015; 290
Kim (10.1016/j.ncrna.2024.07.003_bib188) 2021; 192
Teng (10.1016/j.ncrna.2024.07.003_bib20) 2020; 8
Jeong (10.1016/j.ncrna.2024.07.003_bib91) 2012; 40
Siegel (10.1016/j.ncrna.2024.07.003_bib1) 2022; 72
Yang (10.1016/j.ncrna.2024.07.003_bib165) 2021; 9
Cheng (10.1016/j.ncrna.2024.07.003_bib31) 2020; 13
Anastasiadou (10.1016/j.ncrna.2024.07.003_bib35) 2018; 18
Zhang (10.1016/j.ncrna.2024.07.003_bib94) 2020; 39
Isin (10.1016/j.ncrna.2024.07.003_bib181) 2015; 6
Bhagirath (10.1016/j.ncrna.2024.07.003_bib98) 2018; 78
Sung (10.1016/j.ncrna.2024.07.003_bib82) 2021; 56
Zhang (10.1016/j.ncrna.2024.07.003_bib72) 2015; 14
Zhang (10.1016/j.ncrna.2024.07.003_bib95) 2020; 57
Zhang (10.1016/j.ncrna.2024.07.003_bib157) 2022; 24
Pinsky (10.1016/j.ncrna.2024.07.003_bib9
References_xml – volume: 22
  start-page: 574
  year: 2015
  end-page: 582
  ident: bib78
  article-title: Loss of JUNB/AP-1 promotes invasive prostate cancer
  publication-title: Cell Death Differ.
– volume: 234
  start-page: 16885
  year: 2019
  end-page: 16903
  ident: bib46
  article-title: Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy
  publication-title: J. Cell. Physiol.
– volume: 1
  start-page: 53
  year: 2015
  end-page: 68
  ident: bib36
  article-title: Exosomal non-coding RNAs: diagnostic, prognostic and therapeutic applications in cancer
  publication-title: Noncoding RNA
– volume: 13
  year: 2021
  ident: bib178
  article-title: A novel urine exosomal lncRNA assay to improve the detection of prostate cancer at initial biopsy: a retrospective multicenter diagnostic feasibility study
  publication-title: Cancers
– volume: 9
  start-page: 19723
  year: 2024
  end-page: 19731
  ident: bib169
  article-title: Dumbbell dual-hairpin triggered DNA nanonet assembly for cascade-amplified sensing of exosomal MicroRNA
  publication-title: ACS Omega
– volume: 40
  start-page: 1697
  year: 2012
  end-page: 1704
  ident: bib91
  article-title: Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt
  publication-title: Int. J. Oncol.
– volume: 8
  start-page: 71
  year: 2017
  ident: bib136
  article-title: Therapeutic approaches targeting MYC-driven prostate cancer
  publication-title: Genes
– volume: 19
  start-page: 141
  year: 2013
  end-page: 157
  ident: bib40
  article-title: Circular RNAs are abundant, conserved, and associated with ALU repeats
  publication-title: RNA
– volume: 6
  start-page: 168
  year: 2015
  ident: bib181
  article-title: Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
  publication-title: Front. Genet.
– volume: 74
  start-page: 4183
  year: 2014
  end-page: 4195
  ident: bib159
  article-title: miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells
  publication-title: Cancer Res.
– volume: 17
  start-page: 82
  year: 2018
  ident: bib16
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol. Cancer
– volume: 142
  start-page: 556
  year: 2020
  end-page: 574
  ident: bib198
  article-title: Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models
  publication-title: Circulation
– volume: 32
  start-page: 704
  year: 2012
  end-page: 711
  ident: bib50
  article-title: Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus
  publication-title: Arterioscler. Thromb. Vasc. Biol.
– volume: 19
  start-page: 201
  year: 2022
  end-page: 218
  ident: bib19
  article-title: Prostate luminal progenitor cells: from mouse to human, from health to disease
  publication-title: Nat. Rev. Urol.
– year: 2022
  ident: bib21
  article-title: Exosomes: small vesicles with big roles in cancer, vaccine development, and therapeutics
  publication-title: Bioact. Mater.
– volume: 67
  start-page: 33
  year: 2015
  end-page: 41
  ident: bib184
  article-title: Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
  publication-title: Eur. Urol.
– volume: 8
  start-page: 8822
  year: 2018
  ident: bib26
  article-title: Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion
  publication-title: Sci. Rep.
– volume: 11
  year: 2016
  ident: bib172
  article-title: Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients
  publication-title: PLoS One
– volume: 1095
  start-page: 101
  year: 2018
  end-page: 110
  ident: bib158
  article-title: Epithelial-mesenchymal transition (EMT) and prostate cancer
  publication-title: Adv. Exp. Med. Biol.
– volume: 77
  start-page: 416
  year: 2016
  end-page: 420
  ident: bib186
  article-title: Coupling hybridization chain reaction with catalytic hairpin assembly enables non-enzymatic and sensitive fluorescent detection of microRNA cancer biomarkers
  publication-title: Biosens. Bioelectron.
– volume: 6
  year: 2016
  ident: bib180
  article-title: Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes
  publication-title: Sci. Rep.
– volume: 46
  start-page: 532
  year: 2018
  end-page: 545
  ident: bib179
  article-title: Tumor-derived exosomal long noncoding RNAs as promising diagnostic biomarkers for prostate cancer
  publication-title: Cell. Physiol. Biochem.
– volume: 27
  start-page: 1718
  year: 2019
  end-page: 1725
  ident: bib34
  article-title: ncRNA-encoded peptides or proteins and cancer
  publication-title: Mol. Ther.
– volume: 4
  start-page: 119
  year: 2021
  ident: bib104
  article-title: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
  publication-title: Commun. Biol.
– volume: 32
  start-page: 983
  year: 2014
  end-page: 997
  ident: bib101
  article-title: Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes
  publication-title: Stem Cell.
– volume: 6
  year: 2020
  ident: bib28
  article-title: Proteomic analysis of circulating extracellular vesicles
  publication-title: Sci. Adv.
– volume: 192
  year: 2021
  ident: bib188
  article-title: Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer
  publication-title: Biosens. Bioelectron.
– volume: 117
  year: 2019
  ident: bib99
  article-title: Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma
  publication-title: Biomed. Pharmacother.
– volume: 6
  year: 2016
  ident: bib190
  article-title: Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy
  publication-title: Sci. Rep.
– volume: 60
  start-page: 81
  year: 2018
  end-page: 91
  ident: bib83
  article-title: Extracellular vesicles in obesity and diabetes mellitus
  publication-title: Mol. Aspect. Med.
– volume: 66
  start-page: 203
  year: 2019
  end-page: 210
  ident: bib68
  article-title: Skullcapflavone I inhibits proliferation of human colorectal cancer cells via down-regulation of miR-107 expression
  publication-title: Neoplasma
– volume: 13
  start-page: 395
  year: 2018
  end-page: 412
  ident: bib97
  article-title: Epithelial mesenchymal transition in tumor metastasis
  publication-title: Annu. Rev. Pathol.
– volume: 19
  start-page: 367
  year: 2022
  end-page: 380
  ident: bib3
  article-title: Regulation and role of CAMKK2 in prostate cancer
  publication-title: Nat. Rev. Urol.
– volume: 18
  start-page: 90
  year: 2019
  ident: bib39
  article-title: Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
  publication-title: Mol. Cancer
– volume: 16
  start-page: 149
  year: 2018
  end-page: 154
  ident: bib168
  article-title: Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis
  publication-title: Ann. Fam. Med.
– volume: 52
  start-page: 1809
  year: 2020
  end-page: 1822
  ident: bib130
  article-title: Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-beta signaling pathway
  publication-title: Exp. Mol. Med.
– volume: 33
  start-page: 72
  year: 2014
  ident: bib126
  article-title: Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 11
  start-page: e493
  year: 2021
  ident: bib145
  article-title: LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axis
  publication-title: Clin. Transl. Med.
– volume: 46
  start-page: 69
  year: 2021
  ident: bib150
  article-title: Exosomal circRNA HIPK3 knockdown inhibited cell proliferation and metastasis in prostate cancer by regulating miR-212/BMI-1 pathway
  publication-title: J. Biosci.
– volume: 77
  start-page: 573
  year: 2017
  end-page: 583
  ident: bib51
  article-title: Exosomal and non-exosomal urinary miRNAs in prostate cancer detection and prognosis
  publication-title: Prostate
– volume: 13
  start-page: 2004
  year: 2022
  end-page: 2016
  ident: bib61
  article-title: Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis
  publication-title: Bioengineered
– volume: 19
  start-page: 101
  year: 2022
  end-page: 115
  ident: bib18
  article-title: Prostate zones and cancer: lost in transition?
  publication-title: Nat. Rev. Urol.
– volume: 216
  year: 2020
  ident: bib87
  article-title: circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis
  publication-title: Pathol. Res. Pract.
– volume: 78
  start-page: 1833
  year: 2018
  end-page: 1844
  ident: bib98
  article-title: microRNA-1246 is an exosomal biomarker for aggressive prostate cancer
  publication-title: Cancer Res.
– volume: 38
  start-page: 495
  year: 2019
  ident: bib74
  article-title: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 235
  start-page: 9729
  year: 2020
  end-page: 9742
  ident: bib77
  article-title: Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer
  publication-title: J. Cell. Physiol.
– volume: 470
  start-page: 269
  year: 2011
  end-page: 273
  ident: bib92
  article-title: SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
  publication-title: Nature
– volume: 392
  start-page: 2052
  year: 2018
  end-page: 2090
  ident: bib4
  article-title: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
  publication-title: Lancet
– volume: 630
  year: 2021
  ident: bib187
  article-title: Determination of miRNA derived from exosomes of prostate cancer via toehold-aided cyclic amplification combined with HRP enzyme catalysis and magnetic nanoparticles
  publication-title: Anal. Biochem.
– volume: 10
  year: 2020
  ident: bib142
  article-title: Long non-coding RNA SNHG1 regulates the Wnt/beta-catenin and PI3K/AKT/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell
  publication-title: Front. Oncol.
– volume: 14
  start-page: 598
  year: 2014
  end-page: 610
  ident: bib73
  article-title: FAK in cancer: mechanistic findings and clinical applications
  publication-title: Nat. Rev. Cancer
– volume: 2022
  year: 2022
  ident: bib66
  article-title: Integrative analysis of bulk RNA-Seq and single-cell RNA-Seq unveils the characteristics of the immune microenvironment and prognosis signature in prostate cancer
  publication-title: J. Oncol.
– volume: 1871
  start-page: 455
  year: 2019
  end-page: 468
  ident: bib11
  article-title: Exosomes in cancer development, metastasis, and immunity
  publication-title: Biochim. Biophys. Acta Rev. Canc
– volume: 11
  year: 2020
  ident: bib55
  article-title: Extracellular vesicles-mediated transfer of miRNA let-7b from PC3 cells to macrophages
  publication-title: Genes
– volume: 12
  start-page: 1129
  year: 2021
  ident: bib143
  article-title: Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis
  publication-title: Cell Death Dis.
– volume: 20
  start-page: 351
  year: 2018
  end-page: 363
  ident: bib129
  article-title: EAF2 and p53 Co-regulate STAT3 activation in prostate cancer
  publication-title: Neoplasia
– volume: 23
  year: 2022
  ident: bib85
  article-title: Secreted miR-153 controls proliferation and invasion of higher Gleason score prostate cancer
  publication-title: Int. J. Mol. Sci.
– volume: 11
  year: 2016
  ident: bib120
  article-title: CXCL12/CXCR4 Axis activation mediates prostate myofibroblast phenoconversion through non-canonical EGFR/MEK/ERK signaling
  publication-title: PLoS One
– volume: 11
  year: 2019
  ident: bib106
  article-title: Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells
  publication-title: Cancers
– volume: 22
  start-page: 522
  year: 2015
  end-page: 523
  ident: bib79
  article-title: JunB and PTEN in prostate cancer: 'loss is nothing else than change'
  publication-title: Cell Death Differ.
– volume: 125
  start-page: 2965
  year: 2019
  end-page: 2974
  ident: bib9
  article-title: Metastatic prostate cancer at diagnosis and through progression in the prostate, lung, colorectal, and ovarian cancer screening trial
  publication-title: Cancer
– volume: 20
  year: 2021
  ident: bib155
  article-title: LncRNA BLACAT1 promotes proliferation, migration and invasion of prostate cancer cells via regulating miR-29a-3p/DVL3 Axis
  publication-title: Technol. Cancer Res. Treat.
– volume: 13
  start-page: 11595
  year: 2020
  end-page: 11606
  ident: bib70
  article-title: Functional implication of exosomal miR-217 and miR-23b-3p in the progression of prostate cancer
  publication-title: OncoTargets Ther.
– volume: 80
  start-page: 977
  year: 2020
  end-page: 985
  ident: bib90
  article-title: Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells
  publication-title: Prostate
– volume: 30
  start-page: 138
  year: 2019
  end-page: 143
  ident: bib167
  article-title: Liquid biopsy: a new avenue in pathology
  publication-title: Cytopathology
– volume: 2022
  year: 2022
  ident: bib148
  article-title: Exosomal LINC01213 plays a role in the transition of androgen-dependent prostate cancer cells into androgen-independent manners
  publication-title: J. Oncol.
– volume: 23
  year: 2022
  ident: bib117
  article-title: Exosomal miRNAs from prostate cancer impair osteoblast function in mice
  publication-title: Int. J. Mol. Sci.
– volume: 275
  start-page: 5703
  year: 2008
  end-page: 5713
  ident: bib163
  article-title: Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells
  publication-title: FEBS J.
– volume: 21
  year: 2020
  ident: bib47
  article-title: Exosomes in angiogenesis and anti-angiogenic therapy in cancers
  publication-title: Int. J. Mol. Sci.
– volume: 69
  start-page: 7165
  year: 2009
  end-page: 7169
  ident: bib124
  article-title: miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth
  publication-title: Cancer Res.
– volume: 8
  year: 2020
  ident: bib183
  article-title: The identification of plasma exosomal miR-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development by plasma exosomal miRNA sequencing
  publication-title: Front. Cell Dev. Biol.
– volume: 11
  start-page: e426
  year: 2021
  ident: bib62
  article-title: m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization
  publication-title: Clin. Transl. Med.
– volume: 117
  start-page: 52
  year: 2015
  end-page: 64
  ident: bib191
  article-title: Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction
  publication-title: Circ. Res.
– volume: 8
  start-page: 94834
  year: 2017
  end-page: 94849
  ident: bib108
  article-title: Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
  publication-title: Oncotarget
– volume: 1839
  start-page: 297
  year: 2014
  end-page: 305
  ident: bib144
  article-title: FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells
  publication-title: Biochim. Biophys. Acta
– volume: 367
  year: 2020
  ident: bib22
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science
– volume: 145
  year: 2020
  ident: bib14
  article-title: Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer
  publication-title: Crit. Rev. Oncol. Hematol.
– volume: 21
  start-page: 185
  year: 2013
  end-page: 191
  ident: bib195
  article-title: Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells
  publication-title: Mol. Ther.
– volume: 74
  start-page: 1320
  year: 2014
  end-page: 1334
  ident: bib131
  article-title: miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
  publication-title: Prostate
– volume: 8
  start-page: 222
  year: 2018
  ident: bib24
  article-title: Extracellular vesicles in prostate cancer carcinogenesis, diagnosis, and management
  publication-title: Front. Oncol.
– volume: 290
  start-page: 4545
  year: 2015
  end-page: 4551
  ident: bib25
  article-title: The alphavbeta6 integrin is transferred intercellularly via exosomes
  publication-title: J. Biol. Chem.
– volume: 502
  start-page: 262
  year: 2018
  end-page: 268
  ident: bib141
  article-title: The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 42
  start-page: 1307
  year: 2019
  end-page: 1318
  ident: bib133
  article-title: Transcriptional regulation of FoxM1 by HIF-1alpha mediates hypoxia-induced EMT in prostate cancer
  publication-title: Oncol. Rep.
– volume: 10
  start-page: 5313
  year: 2020
  ident: bib57
  article-title: Extracellular vesicles derived from human adipose-derived stem cells promote the exogenous angiogenesis of fat grafts via the let-7/AGO1/VEGF signalling pathway
  publication-title: Sci. Rep.
– volume: 135
  start-page: 584
  year: 2022
  end-page: 590
  ident: bib2
  article-title: Cancer statistics in China and United States, 2022: profiles, trends, and determinants
  publication-title: Chinese Med J
– volume: 17
  start-page: 4463
  year: 2019
  end-page: 4473
  ident: bib110
  article-title: Exosomes from LNCaP cells promote osteoblast activity through miR-375 transfer
  publication-title: Oncol. Lett.
– volume: 12
  start-page: 31
  year: 2022
  end-page: 46
  ident: bib43
  article-title: Hallmarks of cancer: new dimensions
  publication-title: Cancer Discov.
– volume: 56
  start-page: 1861
  year: 2021
  end-page: 1874
  ident: bib82
  article-title: Extracellular vesicles: critical players during cell migration
  publication-title: Dev. Cell
– volume: 140
  start-page: 3198
  year: 2013
  end-page: 3209
  ident: bib115
  article-title: Rho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition
  publication-title: Development
– volume: 106
  start-page: 768
  year: 2012
  end-page: 774
  ident: bib177
  article-title: Changes in circulating microRNA levels associated with prostate cancer
  publication-title: Br. J. Cancer
– volume: 19
  start-page: 562
  year: 2022
  end-page: 572
  ident: bib6
  article-title: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
  publication-title: Nat. Rev. Urol.
– volume: 14
  start-page: 683
  year: 2017
  end-page: 696
  ident: bib149
  article-title: WNT signalling in prostate cancer
  publication-title: Nat. Rev. Urol.
– volume: 16
  start-page: 669
  year: 2018
  end-page: 681
  ident: bib88
  article-title: Characterization and evidence of the miR-888 cluster as a novel cancer network in prostate
  publication-title: Mol. Cancer Res.
– volume: 87
  year: 2021
  ident: bib48
  article-title: Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro
  publication-title: Cell. Signal.
– volume: 7
  year: 2012
  ident: bib103
  article-title: Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway
  publication-title: PLoS One
– volume: 7
  start-page: 64
  year: 2007
  ident: bib146
  article-title: Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
  publication-title: BMC Cancer
– volume: 71
  start-page: 2193
  year: 2011
  end-page: 2202
  ident: bib164
  article-title: PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway
  publication-title: Cancer Res.
– volume: 123
  start-page: 1057
  year: 2013
  end-page: 1067
  ident: bib56
  article-title: Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
  publication-title: J. Clin. Invest.
– volume: 11
  year: 2021
  ident: bib76
  article-title: Morphometric analysis of rat prostate development: roles of MEK/ERK and Rho signaling pathways in prostatic morphogenesis
  publication-title: Biomolecules
– volume: 7
  start-page: 682
  year: 2010
  end-page: 693
  ident: bib152
  article-title: Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation
  publication-title: Cell Stem Cell
– volume: 10
  start-page: 7656
  year: 2020
  end-page: 7670
  ident: bib132
  article-title: TGF-Beta causes docetaxel resistance in prostate cancer via the induction of Bcl-2 by acetylated KLF5 and protein stabilization
  publication-title: Theranostics
– volume: 9
  start-page: 258
  year: 2010
  ident: bib112
  article-title: Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis
  publication-title: Mol. Cancer
– volume: 8
  year: 2020
  ident: bib185
  article-title: An eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer
  publication-title: Front. Cell Dev. Biol.
– volume: 277
  start-page: 43924
  year: 2002
  end-page: 43932
  ident: bib75
  article-title: The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization
  publication-title: J. Biol. Chem.
– volume: 47
  start-page: 710
  year: 2015
  end-page: 718
  ident: bib100
  article-title: MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer
  publication-title: Int. J. Oncol.
– volume: 20
  start-page: 470
  year: 2020
  ident: bib107
  article-title: Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer
  publication-title: Cancer Cell Int.
– volume: 21
  start-page: 145
  year: 2021
  ident: bib65
  article-title: Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1
  publication-title: Cancer Cell Int.
– volume: 25
  start-page: 1409
  year: 2017
  end-page: 1419
  ident: bib69
  article-title: MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1
  publication-title: Oncol. Res.
– volume: 42
  start-page: 354
  year: 2021
  end-page: 373
  ident: bib147
  article-title: Hormonal therapy for prostate cancer
  publication-title: Endocr. Rev.
– volume: 9
  start-page: 139
  year: 2016
  end-page: 148
  ident: bib176
  article-title: Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients
  publication-title: OncoTargets Ther.
– volume: 21
  start-page: 911
  year: 2017
  end-page: 920
  ident: bib134
  article-title: Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression
  publication-title: Expert Opin. Ther. Targets
– volume: 25
  start-page: 981
  year: 2015
  end-page: 984
  ident: bib41
  article-title: Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
  publication-title: Cell Res.
– volume: 392
  start-page: 1789
  year: 2018
  end-page: 1858
  ident: bib8
  article-title: Incidence Injury and Collaborators Prevalence, Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
  publication-title: Lancet
– volume: 6
  year: 2011
  ident: bib54
  article-title: MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression
  publication-title: PLoS One
– volume: 40
  start-page: 59
  year: 2021
  ident: bib137
  article-title: USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 1876
  year: 2021
  ident: bib166
  article-title: miRNAs and androgen deprivation therapy for prostate cancer
  publication-title: Biochim. Biophys. Acta Rev. Canc
– volume: 77
  start-page: 1167
  year: 2017
  end-page: 1175
  ident: bib173
  article-title: MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method
  publication-title: Prostate
– volume: 343
  start-page: 107
  year: 2022
  end-page: 117
  ident: bib197
  article-title: Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy
  publication-title: J. Contr. Release
– volume: 410
  start-page: 100
  year: 2017
  end-page: 111
  ident: bib121
  article-title: Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling
  publication-title: Cancer Lett.
– volume: 179
  start-page: 1033
  year: 2019
  end-page: 1055
  ident: bib38
  article-title: The role of non-coding RNAs in oncology
  publication-title: Cell
– volume: 72
  start-page: 7
  year: 2022
  end-page: 33
  ident: bib1
  article-title: Cancer statistics
  publication-title: Ca-Cancer J. Clin.
– volume: 6
  start-page: 34446
  year: 2015
  end-page: 34457
  ident: bib151
  article-title: MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
  publication-title: Oncotarget
– volume: 214
  start-page: 295
  year: 2008
  end-page: 300
  ident: bib89
  article-title: Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements
  publication-title: J. Cell. Physiol.
– volume: 8
  start-page: 1145
  year: 2017
  ident: bib37
  article-title: Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
  publication-title: Nat. Commun.
– volume: 115
  start-page: 2204
  year: 2018
  end-page: 2209
  ident: bib113
  article-title: Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
– volume: 20
  start-page: 50
  year: 2022
  ident: bib196
  article-title: Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
  publication-title: J. Nanobiotechnol.
– volume: 17
  year: 2016
  ident: bib12
  article-title: Prostate cancer detection and prognosis: from prostate specific antigen (PSA) to exosomal biomarkers
  publication-title: Int. J. Mol. Sci.
– volume: 17
  start-page: 147
  year: 2018
  ident: bib15
  article-title: Effect of exosomal miRNA on cancer biology and clinical applications
  publication-title: Mol. Cancer
– volume: 7
  year: 2017
  ident: bib49
  article-title: Regulation of TFPIalpha expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens
  publication-title: Sci. Rep.
– volume: 8
  start-page: 7820
  year: 2018
  ident: bib71
  article-title: MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
  publication-title: Sci. Rep.
– volume: 5
  start-page: 2723
  year: 2014
  end-page: 2735
  ident: bib64
  article-title: Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
  publication-title: Oncotarget
– volume: 20
  start-page: 99
  year: 2021
  ident: bib42
  article-title: Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications
  publication-title: Mol. Cancer
– volume: 100
  start-page: 57
  year: 2000
  end-page: 70
  ident: bib45
  article-title: The hallmarks of cancer
  publication-title: Cell
– volume: 13
  start-page: 6293
  year: 2022
  end-page: 6308
  ident: bib63
  article-title: Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer
  publication-title: Bioengineered
– volume: 57
  start-page: 540
  year: 2020
  end-page: 549
  ident: bib95
  article-title: MicroRNA-137 regulates hypoxia-mediated migration and epithelial-mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway
  publication-title: Int. J. Oncol.
– volume: 18
  start-page: 75
  year: 2019
  ident: bib27
  article-title: Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
  publication-title: Mol. Cancer
– volume: 12
  start-page: 53
  year: 2019
  ident: bib81
  article-title: Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
  publication-title: J. Hematol. Oncol.
– volume: 8
  year: 2020
  ident: bib20
  article-title: Shedding light on extracellular vesicle biogenesis and bioengineering
  publication-title: Adv. Sci.
– volume: 17
  start-page: 730
  year: 2017
  ident: bib53
  article-title: Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
  publication-title: BMC Cancer
– volume: 12
  start-page: 10194
  year: 2020
  end-page: 10210
  ident: bib128
  article-title: Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
  publication-title: Aging (Albany NY)
– volume: 16
  start-page: 156
  year: 2017
  ident: bib170
  article-title: Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
  publication-title: Mol. Cancer
– volume: 13
  start-page: 9
  year: 2020
  ident: bib31
  article-title: Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
  publication-title: J. Ovarian Res.
– volume: 12
  year: 2020
  ident: bib199
  article-title: Development of antibody-oligonucleotide complexes for targeting exosomal MicroRNA
  publication-title: Pharmaceutics
– volume: 6
  start-page: 483
  year: 2004
  end-page: 495
  ident: bib114
  article-title: Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment
  publication-title: Dev. Cell
– volume: 39
  start-page: 542
  year: 2018
  end-page: 551
  ident: bib192
  article-title: Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
  publication-title: Acta Pharmacol. Sin.
– volume: 16
  start-page: 176
  year: 2017
  ident: bib80
  article-title: Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis
  publication-title: Mol. Cancer
– volume: 39
  start-page: 81
  year: 2018
  end-page: 90
  ident: bib93
  article-title: Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TGF-beta signaling in prostate cancer
  publication-title: Oncol. Rep.
– volume: 9
  start-page: 315
  year: 2016
  end-page: 324
  ident: bib194
  article-title: Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication
  publication-title: Cell. Mol. Bioeng.
– volume: 187
  start-page: 172
  year: 2020
  ident: bib13
  article-title: Strand displacement-triggered G-quadruplex/rolling circle amplification strategy for the ultra-sensitive electrochemical sensing of exosomal microRNAs
  publication-title: Mikrochim. Acta
– volume: 23
  start-page: 11043
  year: 2019
  end-page: 11050
  ident: bib111
  article-title: Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 73
  start-page: 1232
  year: 2013
  end-page: 1244
  ident: bib122
  article-title: Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
  publication-title: Cancer Res.
– volume: 1
  start-page: e105
  year: 2010
  ident: bib123
  article-title: Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
  publication-title: Cell Death Dis.
– volume: 8
  year: 2013
  ident: bib153
  article-title: Bmi-1 promotes glioma angiogenesis by activating NF-kappaB signaling
  publication-title: PLoS One
– volume: 2022
  year: 2022
  ident: bib140
  article-title: Exosomal CXCL14 contributes to M2 macrophage polarization through NF-kappaB signaling in prostate cancer
  publication-title: Oxid. Med. Cell. Longev.
– volume: 50
  start-page: 1
  year: 2018
  end-page: 10
  ident: bib30
  article-title: The implications of signaling lipids in cancer metastasis
  publication-title: Exp. Mol. Med.
– volume: 15
  start-page: 86
  year: 2019
  ident: bib32
  article-title: Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer
  publication-title: Metabolomics
– volume: 18
  start-page: 116
  year: 2019
  ident: bib17
  article-title: Exosomal circRNAs: biogenesis, effect and application in human diseases
  publication-title: Mol. Cancer
– volume: 11
  start-page: 466
  year: 2020
  ident: bib86
  article-title: KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1
  publication-title: Cell Death Dis.
– volume: 383
  start-page: 280
  year: 2009
  end-page: 285
  ident: bib67
  article-title: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 40
  start-page: D1241
  year: 2012
  end-page: D1244
  ident: bib23
  article-title: ExoCarta 2012: database of exosomal proteins, RNA and lipids
  publication-title: Nucleic Acids Res.
– volume: 40
  start-page: 2814
  year: 2018
  end-page: 2825
  ident: bib135
  article-title: Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis
  publication-title: Oncol. Rep.
– volume: 36
  start-page: 6336
  year: 2017
  end-page: 6347
  ident: bib102
  article-title: miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance
  publication-title: Oncogene
– volume: 14
  start-page: 2142
  year: 2015
  end-page: 2148
  ident: bib72
  article-title: Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer
  publication-title: Cell Cycle
– volume: 22
  year: 2021
  ident: bib156
  article-title: Inhibition of BMI-1 induces apoptosis through downregulation of DUB3-mediated Mcl-1 stabilization
  publication-title: Int. J. Mol. Sci.
– volume: 146
  year: 2019
  ident: bib189
  article-title: Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis
  publication-title: Biosens. Bioelectron.
– volume: 19
  start-page: 547
  year: 2022
  end-page: 561
  ident: bib5
  article-title: Race and prostate cancer: genomic landscape
  publication-title: Nat. Rev. Urol.
– volume: 76
  start-page: 68
  year: 2016
  end-page: 79
  ident: bib52
  article-title: Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: application for prostate cancer diagnostic
  publication-title: Prostate
– volume: 11
  start-page: 31
  year: 2011
  ident: bib96
  article-title: Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
  publication-title: BMC Cancer
– volume: 30
  year: 2021
  ident: bib116
  article-title: Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2/RUNX2 cascade
  publication-title: Cell Transplant.
– volume: 10
  year: 2021
  ident: bib119
  article-title: Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p
  publication-title: J. Extracell. Vesicles
– volume: 19
  start-page: 117
  year: 2020
  ident: bib58
  article-title: Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-beta1 axis
  publication-title: Mol. Cancer
– volume: 67
  start-page: 1314
  year: 2020
  end-page: 1318
  ident: bib175
  article-title: Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer
  publication-title: Neoplasma
– volume: 69
  start-page: 168
  year: 2009
  end-page: 180
  ident: bib118
  article-title: PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells
  publication-title: Prostate
– volume: 13
  start-page: 25
  year: 2021
  end-page: 35
  ident: bib171
  article-title: Identification of urinary exosomal miRNAs for the non-invasive diagnosis of prostate cancer
  publication-title: Cancer Manag. Res.
– volume: 36
  start-page: 53
  year: 2017
  ident: bib59
  article-title: Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 18
  start-page: 5
  year: 2018
  end-page: 18
  ident: bib35
  article-title: Non-coding RNA networks in cancer
  publication-title: Nat. Rev. Cancer
– volume: 259
  start-page: 135
  year: 2017
  end-page: 139
  ident: bib174
  article-title: Urinary-exosomal miR-2909: a novel pathognomonic trait of prostate cancer severity
  publication-title: J. Biotechnol.
– volume: 11
  start-page: 88
  year: 2013
  ident: bib193
  article-title: Exosomes are natural carriers of exogenous siRNA to human cells in vitro
  publication-title: Cell Commun. Signal.
– volume: 22
  start-page: 6176
  year: 2016
  end-page: 6191
  ident: bib160
  article-title: BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer
  publication-title: Clin. Cancer Res.
– volume: 9
  year: 2021
  ident: bib165
  article-title: Androgen receptor-related non-coding RNAs in prostate cancer
  publication-title: Front. Cell Dev. Biol.
– volume: 60
  start-page: 1346
  year: 2022
  end-page: 1361
  ident: bib182
  article-title: Circ_0044516 enriches the level of SARM1 as a miR-330-5p sponge to regulate cell malignant behaviors and tumorigenesis of prostate cancer
  publication-title: Biochem. Genet.
– volume: 15
  start-page: 1835
  year: 2021
  end-page: 1849
  ident: bib161
  article-title: Exosomal circ-XIAP promotes docetaxel resistance in prostate cancer by regulating miR-1182/TPD52 Axis
  publication-title: Drug Des. Dev. Ther.
– volume: 35
  start-page: 7369
  year: 2014
  end-page: 7382
  ident: bib162
  article-title: Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
  publication-title: Tumour Biol.
– volume: 7
  year: 2016
  ident: bib60
  article-title: Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
  publication-title: Nat. Commun.
– volume: 24
  year: 2022
  ident: bib157
  article-title: Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR-1/MAP 3 K1 axis
  publication-title: J. Gene Med.
– volume: 398
  start-page: 1075
  year: 2021
  end-page: 1090
  ident: bib7
  article-title: Prostate cancer
  publication-title: Lancet
– volume: 126
  start-page: 4585
  year: 2016
  end-page: 4602
  ident: bib105
  article-title: MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
  publication-title: J. Clin. Invest.
– volume: 20
  start-page: 2531
  year: 2021
  end-page: 2546
  ident: bib139
  article-title: Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment
  publication-title: Cell Cycle
– volume: 121
  start-page: 2118
  year: 2020
  end-page: 2126
  ident: bib154
  article-title: Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker
  publication-title: J. Cell. Biochem.
– volume: 1831
  start-page: 1302
  year: 2013
  end-page: 1309
  ident: bib29
  article-title: Molecular lipidomics of exosomes released by PC-3 prostate cancer cells
  publication-title: Biochim. Biophys. Acta
– volume: 39
  start-page: 282
  year: 2020
  ident: bib94
  article-title: Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis
  publication-title: J. Exp. Clin. Cancer Res.
– volume: 20
  start-page: 332
  year: 2018
  end-page: 343
  ident: bib33
  article-title: Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
  publication-title: Nat. Cell Biol.
– volume: 16
  start-page: 95
  year: 2003
  end-page: 101
  ident: bib10
  article-title: Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma
  publication-title: J. Am. Board Fam. Pract.
– volume: 9
  year: 2021
  ident: bib138
  article-title: Circular RNA circ_0057558 controls prostate cancer cell proliferation through regulating miR-206/USP33/c-Myc Axis
  publication-title: Front. Cell Dev. Biol.
– volume: 144
  start-page: 646
  year: 2011
  end-page: 674
  ident: bib44
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
– volume: 5
  start-page: 242
  year: 2020
  ident: bib84
  article-title: Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
  publication-title: Signal Transduct. Targeted Ther.
– volume: 23
  year: 2022
  ident: bib125
  article-title: Role of miRNA-145, 148, and 185 and stem cells in prostate cancer
  publication-title: Int. J. Mol. Sci.
– volume: 515
  start-page: 345
  year: 2019
  end-page: 351
  ident: bib127
  article-title: Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
  publication-title: Biochem. Biophys. Res. Commun.
– volume: 33
  start-page: 724
  year: 2014
  end-page: 733
  ident: bib109
  article-title: DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion
  publication-title: Oncogene
– volume: 77
  start-page: 1167
  issue: 10
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib173
  article-title: MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method
  publication-title: Prostate
  doi: 10.1002/pros.23376
– volume: 73
  start-page: 1232
  issue: 3
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib122
  article-title: Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-12-2968
– volume: 22
  issue: 18
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib156
  article-title: Inhibition of BMI-1 induces apoptosis through downregulation of DUB3-mediated Mcl-1 stabilization
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms221810107
– volume: 46
  start-page: 532
  issue: 2
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib179
  article-title: Tumor-derived exosomal long noncoding RNAs as promising diagnostic biomarkers for prostate cancer
  publication-title: Cell. Physiol. Biochem.
  doi: 10.1159/000488620
– volume: 8
  issue: 1
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib153
  article-title: Bmi-1 promotes glioma angiogenesis by activating NF-kappaB signaling
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0055527
– volume: 17
  start-page: 4463
  issue: 5
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib110
  article-title: Exosomes from LNCaP cells promote osteoblast activity through miR-375 transfer
  publication-title: Oncol. Lett.
– volume: 7
  start-page: 682
  issue: 6
  year: 2010
  ident: 10.1016/j.ncrna.2024.07.003_bib152
  article-title: Bmi-1 is a crucial regulator of prostate stem cell self-renewal and malignant transformation
  publication-title: Cell Stem Cell
  doi: 10.1016/j.stem.2010.11.013
– volume: 11
  issue: 6
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib172
  article-title: Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0157566
– volume: 20
  start-page: 332
  issue: 3
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib33
  article-title: Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation
  publication-title: Nat. Cell Biol.
  doi: 10.1038/s41556-018-0040-4
– volume: 9
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib138
  article-title: Circular RNA circ_0057558 controls prostate cancer cell proliferation through regulating miR-206/USP33/c-Myc Axis
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2021.644397
– volume: 126
  start-page: 4585
  issue: 12
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib105
  article-title: MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI86505
– volume: 9
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib165
  article-title: Androgen receptor-related non-coding RNAs in prostate cancer
  publication-title: Front. Cell Dev. Biol.
– year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib21
  article-title: Exosomes: small vesicles with big roles in cancer, vaccine development, and therapeutics
  publication-title: Bioact. Mater.
– volume: 7
  start-page: 64
  year: 2007
  ident: 10.1016/j.ncrna.2024.07.003_bib146
  article-title: Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-7-64
– volume: 13
  start-page: 6293
  issue: 3
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib63
  article-title: Circular RNA midline-1 (circMID1) promotes proliferation, migration, invasion and glycolysis in prostate cancer
  publication-title: Bioengineered
  doi: 10.1080/21655979.2022.2037367
– volume: 6
  start-page: 483
  issue: 4
  year: 2004
  ident: 10.1016/j.ncrna.2024.07.003_bib114
  article-title: Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment
  publication-title: Dev. Cell
  doi: 10.1016/S1534-5807(04)00075-9
– volume: 1839
  start-page: 297
  issue: 4
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib144
  article-title: FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbagrm.2014.02.016
– volume: 8
  start-page: 222
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib24
  article-title: Extracellular vesicles in prostate cancer carcinogenesis, diagnosis, and management
  publication-title: Front. Oncol.
  doi: 10.3389/fonc.2018.00222
– volume: 14
  start-page: 683
  issue: 11
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib149
  article-title: WNT signalling in prostate cancer
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/nrurol.2017.144
– volume: 11
  issue: 9
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib106
  article-title: Extracellular vesicles from human advanced-stage prostate cancer cells modify the inflammatory response of microenvironment-residing cells
  publication-title: Cancers
  doi: 10.3390/cancers11091276
– volume: 2022
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib148
  article-title: Exosomal LINC01213 plays a role in the transition of androgen-dependent prostate cancer cells into androgen-independent manners
  publication-title: J. Oncol.
  doi: 10.1155/2022/8058770
– volume: 17
  start-page: 82
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib16
  article-title: Emerging role of exosome-derived long non-coding RNAs in tumor microenvironment
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0831-z
– volume: 115
  start-page: 2204
  issue: 9
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib113
  article-title: Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A
  publication-title: Proc. Natl. Acad. Sci. U.S.A.
  doi: 10.1073/pnas.1717363115
– volume: 20
  start-page: 50
  issue: 1
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib196
  article-title: Exosome-liposome hybrid nanoparticle codelivery of TP and miR497 conspicuously overcomes chemoresistant ovarian cancer
  publication-title: J. Nanobiotechnol.
  doi: 10.1186/s12951-022-01264-5
– volume: 235
  start-page: 9729
  issue: 12
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib77
  article-title: Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.29784
– volume: 18
  start-page: 5
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib35
  article-title: Non-coding RNA networks in cancer
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc.2017.99
– volume: 9
  start-page: 139
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib176
  article-title: Exosomal microRNA-141 is upregulated in the serum of prostate cancer patients
  publication-title: OncoTargets Ther.
– volume: 19
  start-page: 141
  issue: 2
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib40
  article-title: Circular RNAs are abundant, conserved, and associated with ALU repeats
  publication-title: RNA
  doi: 10.1261/rna.035667.112
– volume: 11
  start-page: e493
  issue: 8
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib145
  publication-title: Clin. Transl. Med.
  doi: 10.1002/ctm2.493
– volume: 5
  start-page: 242
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib84
  article-title: Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
  publication-title: Signal Transduct. Targeted Ther.
  doi: 10.1038/s41392-020-00359-5
– volume: 60
  start-page: 81
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib83
  article-title: Extracellular vesicles in obesity and diabetes mellitus
  publication-title: Mol. Aspect. Med.
  doi: 10.1016/j.mam.2017.11.010
– volume: 20
  start-page: 470
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib107
  article-title: Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1/STAT pathway in prostate cancer
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01563-7
– volume: 179
  start-page: 1033
  issue: 5
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib38
  article-title: The role of non-coding RNAs in oncology
  publication-title: Cell
  doi: 10.1016/j.cell.2019.10.017
– volume: 76
  start-page: 68
  issue: 1
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib52
  article-title: Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: application for prostate cancer diagnostic
  publication-title: Prostate
  doi: 10.1002/pros.23101
– volume: 39
  start-page: 282
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib94
  article-title: Loss of exosomal miR-146a-5p from cancer-associated fibroblasts after androgen deprivation therapy contributes to prostate cancer metastasis
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-020-01761-1
– volume: 30
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib116
  article-title: Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2/RUNX2 cascade
  publication-title: Cell Transplant.
  doi: 10.1177/09636897211052977
– volume: 40
  start-page: D1241
  issue: Database issue
  year: 2012
  ident: 10.1016/j.ncrna.2024.07.003_bib23
  article-title: ExoCarta 2012: database of exosomal proteins, RNA and lipids
  publication-title: Nucleic Acids Res.
  doi: 10.1093/nar/gkr828
– volume: 80
  start-page: 977
  issue: 12
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib90
  article-title: Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells
  publication-title: Prostate
  doi: 10.1002/pros.24029
– volume: 39
  start-page: 81
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib93
  article-title: Downregulation of miR-19a-3p promotes invasion, migration and bone metastasis via activating TGF-beta signaling in prostate cancer
  publication-title: Oncol. Rep.
– volume: 47
  start-page: 710
  issue: 2
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib100
  article-title: MicroRNA-26a/b directly regulate La-related protein 1 and inhibit cancer cell invasion in prostate cancer
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2015.3043
– volume: 67
  start-page: 1314
  issue: 6
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib175
  article-title: Plasma exosomal miR-125a-5p and miR-141-5p as non-invasive biomarkers for prostate cancer
  publication-title: Neoplasma
  doi: 10.4149/neo_2020_191130N1234
– volume: 40
  start-page: 2814
  issue: 5
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib135
  article-title: Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis
  publication-title: Oncol. Rep.
– volume: 117
  start-page: 52
  issue: 1
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib191
  article-title: Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction
  publication-title: Circ. Res.
  doi: 10.1161/CIRCRESAHA.117.305990
– volume: 74
  start-page: 1320
  issue: 13
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib131
  article-title: miR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression
  publication-title: Prostate
  doi: 10.1002/pros.22848
– volume: 42
  start-page: 354
  issue: 3
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib147
  article-title: Hormonal therapy for prostate cancer
  publication-title: Endocr. Rev.
  doi: 10.1210/endrev/bnab002
– volume: 72
  start-page: 7
  issue: 1
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib1
  article-title: Cancer statistics
  publication-title: Ca-Cancer J. Clin.
  doi: 10.3322/caac.21708
– volume: 36
  start-page: 6336
  issue: 45
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib102
  article-title: miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance
  publication-title: Oncogene
  doi: 10.1038/onc.2017.240
– volume: 6
  issue: 4
  year: 2011
  ident: 10.1016/j.ncrna.2024.07.003_bib54
  article-title: MiR-21 induced angiogenesis through AKT and ERK activation and HIF-1alpha expression
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0019139
– volume: 7
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib60
  article-title: Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms11150
– volume: 32
  start-page: 983
  issue: 4
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib101
  article-title: Neoplastic reprogramming of patient-derived adipose stem cells by prostate cancer cell-associated exosomes
  publication-title: Stem Cell.
  doi: 10.1002/stem.1619
– volume: 12
  start-page: 31
  issue: 1
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib43
  article-title: Hallmarks of cancer: new dimensions
  publication-title: Cancer Discov.
  doi: 10.1158/2159-8290.CD-21-1059
– volume: 470
  start-page: 269
  issue: 7333
  year: 2011
  ident: 10.1016/j.ncrna.2024.07.003_bib92
  article-title: SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression
  publication-title: Nature
  doi: 10.1038/nature09677
– volume: 1871
  start-page: 455
  issue: 2
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib11
  article-title: Exosomes in cancer development, metastasis, and immunity
  publication-title: Biochim. Biophys. Acta Rev. Canc
  doi: 10.1016/j.bbcan.2019.04.004
– volume: 13
  start-page: 2004
  issue: 2
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib61
  article-title: Human bone marrow mesenchymal stem cells-derived exosomes attenuated prostate cancer progression via the miR-99b-5p/IGF1R axis
  publication-title: Bioengineered
  doi: 10.1080/21655979.2021.2009416
– volume: 4
  start-page: 119
  issue: 1
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib104
  article-title: Circulating extracellular vesicles release oncogenic miR-424 in experimental models and patients with aggressive prostate cancer
  publication-title: Commun. Biol.
  doi: 10.1038/s42003-020-01642-5
– volume: 77
  start-page: 416
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib186
  article-title: Coupling hybridization chain reaction with catalytic hairpin assembly enables non-enzymatic and sensitive fluorescent detection of microRNA cancer biomarkers
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2015.09.053
– volume: 25
  start-page: 1409
  issue: 8
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib69
  article-title: MicroRNA-107 promotes proliferation, migration, and invasion of osteosarcoma cells by targeting tropomyosin 1
  publication-title: Oncol. Res.
  doi: 10.3727/096504017X14882829077237
– volume: 38
  start-page: 495
  issue: 1
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib74
  article-title: Human bone marrow mesenchymal stem cells-derived microRNA-205-containing exosomes impede the progression of prostate cancer through suppression of RHPN2
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-019-1488-1
– volume: 69
  start-page: 7165
  issue: 18
  year: 2009
  ident: 10.1016/j.ncrna.2024.07.003_bib124
  article-title: miR-21: an androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-09-1448
– volume: 11
  start-page: e426
  issue: 6
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib62
  article-title: m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization
  publication-title: Clin. Transl. Med.
  doi: 10.1002/ctm2.426
– volume: 106
  start-page: 768
  issue: 4
  year: 2012
  ident: 10.1016/j.ncrna.2024.07.003_bib177
  article-title: Changes in circulating microRNA levels associated with prostate cancer
  publication-title: Br. J. Cancer
  doi: 10.1038/bjc.2011.595
– volume: 21
  start-page: 185
  issue: 1
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib195
  article-title: Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells
  publication-title: Mol. Ther.
  doi: 10.1038/mt.2012.180
– volume: 117
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib99
  article-title: Prostate carcinoma cell-derived exosomal MicroRNA-26a modulates the metastasis and tumor growth of prostate carcinoma
  publication-title: Biomed. Pharmacother.
  doi: 10.1016/j.biopha.2019.109109
– volume: 56
  start-page: 1861
  issue: 13
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib82
  article-title: Extracellular vesicles: critical players during cell migration
  publication-title: Dev. Cell
  doi: 10.1016/j.devcel.2021.03.020
– volume: 142
  start-page: 556
  issue: 6
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib198
  article-title: Extracellular vesicle-mediated delivery of circular RNA SCMH1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.045765
– volume: 11
  issue: 12
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib76
  article-title: Morphometric analysis of rat prostate development: roles of MEK/ERK and Rho signaling pathways in prostatic morphogenesis
  publication-title: Biomolecules
  doi: 10.3390/biom11121829
– volume: 502
  start-page: 262
  issue: 2
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib141
  article-title: The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2018.05.157
– volume: 19
  start-page: 547
  issue: 9
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib5
  article-title: Race and prostate cancer: genomic landscape
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-022-00622-0
– volume: 410
  start-page: 100
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib121
  article-title: Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2017.09.010
– volume: 343
  start-page: 107
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib197
  article-title: Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy
  publication-title: J. Contr. Release
  doi: 10.1016/j.jconrel.2022.01.026
– volume: 27
  start-page: 1718
  issue: 10
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib34
  article-title: ncRNA-encoded peptides or proteins and cancer
  publication-title: Mol. Ther.
  doi: 10.1016/j.ymthe.2019.09.001
– volume: 42
  start-page: 1307
  issue: 4
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib133
  article-title: Transcriptional regulation of FoxM1 by HIF-1alpha mediates hypoxia-induced EMT in prostate cancer
  publication-title: Oncol. Rep.
– volume: 33
  start-page: 724
  issue: 6
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib109
  article-title: DLC1 induces expression of E-cadherin in prostate cancer cells through Rho pathway and suppresses invasion
  publication-title: Oncogene
  doi: 10.1038/onc.2013.7
– volume: 100
  start-page: 57
  issue: 1
  year: 2000
  ident: 10.1016/j.ncrna.2024.07.003_bib45
  article-title: The hallmarks of cancer
  publication-title: Cell
  doi: 10.1016/S0092-8674(00)81683-9
– volume: 277
  start-page: 43924
  issue: 46
  year: 2002
  ident: 10.1016/j.ncrna.2024.07.003_bib75
  article-title: The RhoA-binding protein, rhophilin-2, regulates actin cytoskeleton organization
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M203569200
– volume: 23
  issue: 3
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib125
  article-title: Role of miRNA-145, 148, and 185 and stem cells in prostate cancer
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23031626
– volume: 6
  start-page: 168
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib181
  article-title: Exosomal lncRNA-p21 levels may help to distinguish prostate cancer from benign disease
  publication-title: Front. Genet.
– volume: 19
  start-page: 101
  issue: 2
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib18
  article-title: Prostate zones and cancer: lost in transition?
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-021-00524-7
– volume: 6
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib180
  article-title: Long non-coding RNAs harboring miRNA seed regions are enriched in prostate cancer exosomes
  publication-title: Sci. Rep.
  doi: 10.1038/srep24922
– volume: 515
  start-page: 345
  issue: 2
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib127
  article-title: Exosome-derived miR-27a produced by PSC-27 cells contributes to prostate cancer chemoresistance through p53
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2019.05.120
– volume: 23
  start-page: 11043
  issue: 24
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib111
  article-title: Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis
  publication-title: Eur. Rev. Med. Pharmacol. Sci.
– volume: 146
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib189
  article-title: Simultaneous multiplexed detection of exosomal microRNAs and surface proteins for prostate cancer diagnosis
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2019.111749
– volume: 69
  start-page: 168
  issue: 2
  year: 2009
  ident: 10.1016/j.ncrna.2024.07.003_bib118
  article-title: PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells
  publication-title: Prostate
  doi: 10.1002/pros.20870
– volume: 22
  start-page: 6176
  issue: 24
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib160
  article-title: BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer
  publication-title: Clin. Cancer Res.
  doi: 10.1158/1078-0432.CCR-15-3107
– volume: 60
  start-page: 1346
  issue: 4
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib182
  article-title: Circ_0044516 enriches the level of SARM1 as a miR-330-5p sponge to regulate cell malignant behaviors and tumorigenesis of prostate cancer
  publication-title: Biochem. Genet.
  doi: 10.1007/s10528-021-10160-w
– volume: 259
  start-page: 135
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib174
  article-title: Urinary-exosomal miR-2909: a novel pathognomonic trait of prostate cancer severity
  publication-title: J. Biotechnol.
  doi: 10.1016/j.jbiotec.2017.07.029
– volume: 21
  issue: 16
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib47
  article-title: Exosomes in angiogenesis and anti-angiogenic therapy in cancers
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21165840
– volume: 16
  start-page: 95
  issue: 2
  year: 2003
  ident: 10.1016/j.ncrna.2024.07.003_bib10
  article-title: Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma
  publication-title: J. Am. Board Fam. Pract.
  doi: 10.3122/jabfm.16.2.95
– volume: 11
  issue: 12
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib55
  article-title: Extracellular vesicles-mediated transfer of miRNA let-7b from PC3 cells to macrophages
  publication-title: Genes
  doi: 10.3390/genes11121495
– volume: 13
  issue: 16
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib178
  article-title: A novel urine exosomal lncRNA assay to improve the detection of prostate cancer at initial biopsy: a retrospective multicenter diagnostic feasibility study
  publication-title: Cancers
  doi: 10.3390/cancers13164075
– volume: 33
  start-page: 72
  issue: 1
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib126
  article-title: Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-014-0072-y
– volume: 630
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib187
  article-title: Determination of miRNA derived from exosomes of prostate cancer via toehold-aided cyclic amplification combined with HRP enzyme catalysis and magnetic nanoparticles
  publication-title: Anal. Biochem.
  doi: 10.1016/j.ab.2021.114336
– volume: 17
  start-page: 147
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib15
  article-title: Effect of exosomal miRNA on cancer biology and clinical applications
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-018-0897-7
– volume: 71
  start-page: 2193
  issue: 6
  year: 2011
  ident: 10.1016/j.ncrna.2024.07.003_bib164
  article-title: PrLZ protects prostate cancer cells from apoptosis induced by androgen deprivation via the activation of Stat3/Bcl-2 pathway
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-10-1791
– volume: 8
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib185
  article-title: An eight-CircRNA assessment model for predicting biochemical recurrence in prostate cancer
  publication-title: Front. Cell Dev. Biol.
  doi: 10.3389/fcell.2020.599494
– volume: 2022
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib140
  article-title: Exosomal CXCL14 contributes to M2 macrophage polarization through NF-kappaB signaling in prostate cancer
  publication-title: Oxid. Med. Cell. Longev.
  doi: 10.1155/2022/7616696
– volume: 367
  issue: 6478
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib22
  article-title: The biology, function, and biomedical applications of exosomes
  publication-title: Science
  doi: 10.1126/science.aau6977
– volume: 14
  start-page: 2142
  issue: 13
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib72
  article-title: Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2015.1041689
– volume: 9
  start-page: 315
  issue: 3
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib194
  article-title: Oncogene knockdown via active loading of small RNAs into extracellular vesicles by sonication
  publication-title: Cell. Mol. Bioeng.
  doi: 10.1007/s12195-016-0457-4
– volume: 8
  start-page: 1145
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib37
  article-title: Coding and noncoding landscape of extracellular RNA released by human glioma stem cells
  publication-title: Nat. Commun.
  doi: 10.1038/s41467-017-01196-x
– volume: 11
  issue: 7
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib120
  article-title: CXCL12/CXCR4 Axis activation mediates prostate myofibroblast phenoconversion through non-canonical EGFR/MEK/ERK signaling
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0159490
– volume: 1
  start-page: e105
  issue: 12
  year: 2010
  ident: 10.1016/j.ncrna.2024.07.003_bib123
  article-title: Downregulation of miR-205 and miR-31 confers resistance to chemotherapy-induced apoptosis in prostate cancer cells
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2010.85
– volume: 74
  start-page: 4183
  issue: 15
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib159
  article-title: miRNA-128 suppresses prostate cancer by inhibiting BMI-1 to inhibit tumor-initiating cells
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-14-0404
– volume: 67
  start-page: 33
  issue: 1
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib184
  article-title: Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer
  publication-title: Eur. Urol.
  doi: 10.1016/j.eururo.2014.07.035
– volume: 1831
  start-page: 1302
  issue: 7
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib29
  article-title: Molecular lipidomics of exosomes released by PC-3 prostate cancer cells
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbalip.2013.04.011
– volume: 78
  start-page: 1833
  issue: 7
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib98
  article-title: microRNA-1246 is an exosomal biomarker for aggressive prostate cancer
  publication-title: Cancer Res.
  doi: 10.1158/0008-5472.CAN-17-2069
– volume: 24
  issue: 8
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib157
  article-title: Inhibition of circ_0081234 reduces prostate cancer tumor growth and metastasis via the miR-1/MAP 3 K1 axis
  publication-title: J. Gene Med.
  doi: 10.1002/jgm.3376
– volume: 7
  issue: 12
  year: 2012
  ident: 10.1016/j.ncrna.2024.07.003_bib103
  article-title: Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0051655
– volume: 8
  start-page: 94834
  issue: 55
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib108
  article-title: Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.22014
– volume: 234
  start-page: 16885
  issue: 10
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib46
  article-title: Tumor-derived exosomes: implication in angiogenesis and antiangiogenesis cancer therapy
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.28374
– volume: 23
  issue: 3
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib117
  article-title: Exosomal miRNAs from prostate cancer impair osteoblast function in mice
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23031285
– volume: 383
  start-page: 280
  issue: 3
  year: 2009
  ident: 10.1016/j.ncrna.2024.07.003_bib67
  article-title: MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells
  publication-title: Biochem. Biophys. Res. Commun.
  doi: 10.1016/j.bbrc.2009.03.077
– volume: 290
  start-page: 4545
  issue: 8
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib25
  article-title: The alphavbeta6 integrin is transferred intercellularly via exosomes
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.C114.617662
– volume: 12
  issue: 6
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib199
  article-title: Development of antibody-oligonucleotide complexes for targeting exosomal MicroRNA
  publication-title: Pharmaceutics
  doi: 10.3390/pharmaceutics12060545
– volume: 8
  start-page: 71
  issue: 2
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib136
  article-title: Therapeutic approaches targeting MYC-driven prostate cancer
  publication-title: Genes
  doi: 10.3390/genes8020071
– volume: 17
  issue: 11
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib12
  article-title: Prostate cancer detection and prognosis: from prostate specific antigen (PSA) to exosomal biomarkers
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms17111784
– volume: 66
  start-page: 203
  issue: 2
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib68
  article-title: Skullcapflavone I inhibits proliferation of human colorectal cancer cells via down-regulation of miR-107 expression
  publication-title: Neoplasma
  doi: 10.4149/neo_2018_180427N279
– volume: 140
  start-page: 3198
  issue: 15
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib115
  article-title: Rho activation is apically restricted by Arhgap1 in neural crest cells and drives epithelial-to-mesenchymal transition
  publication-title: Development
  doi: 10.1242/dev.095448
– volume: 40
  start-page: 59
  issue: 1
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib137
  article-title: USP16 regulates castration-resistant prostate cancer cell proliferation by deubiquitinating and stablizing c-Myc
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-021-01843-8
– volume: 275
  start-page: 5703
  issue: 22
  year: 2008
  ident: 10.1016/j.ncrna.2024.07.003_bib163
  article-title: Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells
  publication-title: FEBS J.
  doi: 10.1111/j.1742-4658.2008.06697.x
– volume: 13
  start-page: 395
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib97
  article-title: Epithelial mesenchymal transition in tumor metastasis
  publication-title: Annu. Rev. Pathol.
  doi: 10.1146/annurev-pathol-020117-043854
– volume: 35
  start-page: 7369
  issue: 8
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib162
  article-title: Tumor protein D52 (TPD52) and cancer-oncogene understudy or understudied oncogene?
  publication-title: Tumour Biol.
  doi: 10.1007/s13277-014-2006-x
– volume: 20
  start-page: 2531
  issue: 23
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib139
  article-title: Exosomal lncAY927529 enhances prostate cancer cell proliferation and invasion through regulating bone microenvironment
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2021.1992853
– volume: 46
  start-page: 69
  issue: 3
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib150
  article-title: Exosomal circRNA HIPK3 knockdown inhibited cell proliferation and metastasis in prostate cancer by regulating miR-212/BMI-1 pathway
  publication-title: J. Biosci.
  doi: 10.1007/s12038-021-00190-2
– volume: 6
  start-page: 34446
  issue: 33
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib151
  article-title: MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.5920
– volume: 20
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib155
  article-title: LncRNA BLACAT1 promotes proliferation, migration and invasion of prostate cancer cells via regulating miR-29a-3p/DVL3 Axis
  publication-title: Technol. Cancer Res. Treat.
  doi: 10.1177/1533033820972342
– volume: 145
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib14
  article-title: Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer
  publication-title: Crit. Rev. Oncol. Hematol.
  doi: 10.1016/j.critrevonc.2019.102860
– volume: 87
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib48
  article-title: Pro-angiogenic effect of PC-3 exosomes in endothelial cells in vitro
  publication-title: Cell. Signal.
  doi: 10.1016/j.cellsig.2021.110126
– volume: 32
  start-page: 704
  issue: 3
  year: 2012
  ident: 10.1016/j.ncrna.2024.07.003_bib50
  article-title: Tissue factor pathway inhibitor blocks angiogenesis via its carboxyl terminus
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.111.243733
– volume: 16
  start-page: 176
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib80
  article-title: Factors involved in cancer metastasis: a better understanding to "seed and soil" hypothesis
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-017-0742-4
– volume: 52
  start-page: 1809
  issue: 11
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib130
  article-title: Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-beta signaling pathway
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-020-0431-z
– volume: 125
  start-page: 2965
  issue: 17
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib9
  article-title: Metastatic prostate cancer at diagnosis and through progression in the prostate, lung, colorectal, and ovarian cancer screening trial
  publication-title: Cancer
  doi: 10.1002/cncr.32176
– volume: 7
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib49
  article-title: Regulation of TFPIalpha expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens
  publication-title: Sci. Rep.
  doi: 10.1038/srep43500
– volume: 8
  start-page: 7820
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib71
  article-title: MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-26050-y
– volume: 36
  start-page: 53
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib59
  article-title: Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells
  publication-title: J. Exp. Clin. Cancer Res.
  doi: 10.1186/s13046-017-0528-y
– volume: 12
  start-page: 10194
  issue: 11
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib128
  article-title: Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103377
– volume: 17
  start-page: 730
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib53
  article-title: Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3737-z
– volume: 14
  start-page: 598
  issue: 9
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib73
  article-title: FAK in cancer: mechanistic findings and clinical applications
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc3792
– volume: 192
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib188
  article-title: Hydrogel-based hybridization chain reaction (HCR) for detection of urinary exosomal miRNAs as a diagnostic tool of prostate cancer
  publication-title: Biosens. Bioelectron.
  doi: 10.1016/j.bios.2021.113504
– volume: 18
  start-page: 90
  issue: 1
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib39
  article-title: Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-019-1002-6
– volume: 30
  start-page: 138
  issue: 2
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib167
  article-title: Liquid biopsy: a new avenue in pathology
  publication-title: Cytopathology
  doi: 10.1111/cyt.12661
– volume: 13
  start-page: 9
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib31
  article-title: Proteomic and lipidomic analysis of exosomes derived from ovarian cancer cells and ovarian surface epithelial cells
  publication-title: J. Ovarian Res.
  doi: 10.1186/s13048-020-0609-y
– volume: 50
  start-page: 1
  issue: 9
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib30
  article-title: The implications of signaling lipids in cancer metastasis
  publication-title: Exp. Mol. Med.
  doi: 10.1038/s12276-018-0150-x
– volume: 15
  start-page: 86
  issue: 6
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib32
  article-title: Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer
  publication-title: Metabolomics
  doi: 10.1007/s11306-019-1550-1
– volume: 16
  start-page: 669
  issue: 4
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib88
  article-title: Characterization and evidence of the miR-888 cluster as a novel cancer network in prostate
  publication-title: Mol. Cancer Res.
  doi: 10.1158/1541-7786.MCR-17-0321
– volume: 121
  start-page: 2118
  issue: 3
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib154
  article-title: Exosome circ_0044516 promotes prostate cancer cell proliferation and metastasis as a potential biomarker
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.28239
– volume: 21
  start-page: 911
  issue: 9
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib134
  article-title: Implications of Bcl-2 and its interplay with other molecules and signaling pathways in prostate cancer progression
  publication-title: Expert Opin. Ther. Targets
  doi: 10.1080/14728222.2017.1369044
– volume: 216
  issue: 11
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib87
  article-title: circCRKL suppresses the progression of prostate cancer cells by regulating the miR-141/KLF5 axis
  publication-title: Pathol. Res. Pract.
  doi: 10.1016/j.prp.2020.153182
– volume: 392
  start-page: 2052
  issue: 10159
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib4
  article-title: Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)31694-5
– volume: 8
  start-page: 8822
  issue: 1
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib26
  article-title: Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-018-27180-z
– volume: 22
  start-page: 522
  issue: 4
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib79
  article-title: JunB and PTEN in prostate cancer: 'loss is nothing else than change'
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2014.232
– volume: 187
  start-page: 172
  issue: 3
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib13
  article-title: Strand displacement-triggered G-quadruplex/rolling circle amplification strategy for the ultra-sensitive electrochemical sensing of exosomal microRNAs
  publication-title: Mikrochim. Acta
  doi: 10.1007/s00604-020-4143-9
– volume: 13
  start-page: 11595
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib70
  article-title: Functional implication of exosomal miR-217 and miR-23b-3p in the progression of prostate cancer
  publication-title: OncoTargets Ther.
  doi: 10.2147/OTT.S272869
– volume: 9
  start-page: 258
  issue: 1
  year: 2010
  ident: 10.1016/j.ncrna.2024.07.003_bib112
  article-title: Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-9-258
– volume: 10
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib142
  article-title: Long non-coding RNA SNHG1 regulates the Wnt/beta-catenin and PI3K/AKT/mTOR signaling pathways via EZH2 to affect the proliferation, apoptosis, and autophagy of prostate cancer cell
  publication-title: Front. Oncol.
– volume: 19
  start-page: 201
  issue: 4
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib19
  article-title: Prostate luminal progenitor cells: from mouse to human, from health to disease
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-021-00561-2
– volume: 12
  start-page: 53
  issue: 1
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib81
  article-title: Exosome-mediated communication in the tumor microenvironment contributes to hepatocellular carcinoma development and progression
  publication-title: J. Hematol. Oncol.
  doi: 10.1186/s13045-019-0739-0
– volume: 8
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib20
  article-title: Shedding light on extracellular vesicle biogenesis and bioengineering
  publication-title: Adv. Sci.
  doi: 10.1002/advs.202003505
– volume: 19
  start-page: 117
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib58
  article-title: Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-beta1 axis
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-020-01235-0
– volume: 19
  start-page: 562
  issue: 9
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib6
  article-title: Serum PSA-based early detection of prostate cancer in Europe and globally: past, present and future
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-022-00638-6
– volume: 20
  start-page: 351
  issue: 4
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib129
  article-title: EAF2 and p53 Co-regulate STAT3 activation in prostate cancer
  publication-title: Neoplasia
  doi: 10.1016/j.neo.2018.01.011
– volume: 144
  start-page: 646
  issue: 5
  year: 2011
  ident: 10.1016/j.ncrna.2024.07.003_bib44
  article-title: Hallmarks of cancer: the next generation
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
– volume: 23
  issue: 11
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib85
  article-title: Secreted miR-153 controls proliferation and invasion of higher Gleason score prostate cancer
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms23116339
– volume: 123
  start-page: 1057
  issue: 3
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib56
  article-title: Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI65344
– volume: 1095
  start-page: 101
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib158
  article-title: Epithelial-mesenchymal transition (EMT) and prostate cancer
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-3-319-95693-0_6
– volume: 6
  year: 2016
  ident: 10.1016/j.ncrna.2024.07.003_bib190
  article-title: Exosomal miR-10a derived from amniotic fluid stem cells preserves ovarian follicles after chemotherapy
  publication-title: Sci. Rep.
– volume: 10
  issue: 3
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib119
  article-title: Exosomes derived from osteogenic tumor activate osteoclast differentiation and concurrently inhibit osteogenesis by transferring COL1A1-targeting miRNA-92a-1-5p
  publication-title: J. Extracell. Vesicles
  doi: 10.1002/jev2.12056
– volume: 10
  start-page: 7656
  issue: 17
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib132
  article-title: TGF-Beta causes docetaxel resistance in prostate cancer via the induction of Bcl-2 by acetylated KLF5 and protein stabilization
  publication-title: Theranostics
  doi: 10.7150/thno.44567
– volume: 11
  start-page: 466
  issue: 6
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib86
  article-title: KLF5 inhibits STAT3 activity and tumor metastasis in prostate cancer by suppressing IGF1 transcription cooperatively with HDAC1
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-020-2671-1
– volume: 77
  start-page: 573
  issue: 6
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib51
  article-title: Exosomal and non-exosomal urinary miRNAs in prostate cancer detection and prognosis
  publication-title: Prostate
  doi: 10.1002/pros.23295
– volume: 11
  start-page: 31
  year: 2011
  ident: 10.1016/j.ncrna.2024.07.003_bib96
  article-title: Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
  publication-title: BMC Cancer
  doi: 10.1186/1471-2407-11-31
– volume: 10
  start-page: 5313
  issue: 1
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib57
  article-title: Extracellular vesicles derived from human adipose-derived stem cells promote the exogenous angiogenesis of fat grafts via the let-7/AGO1/VEGF signalling pathway
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-020-62140-6
– volume: 19
  start-page: 367
  issue: 6
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib3
  article-title: Regulation and role of CAMKK2 in prostate cancer
  publication-title: Nat. Rev. Urol.
  doi: 10.1038/s41585-022-00588-z
– volume: 40
  start-page: 1697
  issue: 5
  year: 2012
  ident: 10.1016/j.ncrna.2024.07.003_bib91
  article-title: Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt
  publication-title: Int. J. Oncol.
– volume: 22
  start-page: 574
  issue: 4
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib78
  article-title: Loss of JUNB/AP-1 promotes invasive prostate cancer
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2014.213
– volume: 11
  start-page: 88
  year: 2013
  ident: 10.1016/j.ncrna.2024.07.003_bib193
  article-title: Exosomes are natural carriers of exogenous siRNA to human cells in vitro
  publication-title: Cell Commun. Signal.
  doi: 10.1186/1478-811X-11-88
– volume: 392
  start-page: 1789
  issue: 10159
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib8
  publication-title: Lancet
  doi: 10.1016/S0140-6736(18)32279-7
– volume: 1876
  issue: 2
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib166
  article-title: miRNAs and androgen deprivation therapy for prostate cancer
  publication-title: Biochim. Biophys. Acta Rev. Canc
– volume: 18
  start-page: 75
  issue: 1
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib27
  article-title: Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-019-0991-5
– volume: 398
  start-page: 1075
  issue: 10305
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib7
  article-title: Prostate cancer
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00950-8
– volume: 8
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib183
  article-title: The identification of plasma exosomal miR-423-3p as a potential predictive biomarker for prostate cancer castration-resistance development by plasma exosomal miRNA sequencing
  publication-title: Front. Cell Dev. Biol.
– volume: 16
  start-page: 149
  issue: 2
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib168
  article-title: Digital rectal examination for prostate cancer screening in primary care: a systematic review and meta-analysis
  publication-title: Ann. Fam. Med.
  doi: 10.1370/afm.2205
– volume: 214
  start-page: 295
  issue: 2
  year: 2008
  ident: 10.1016/j.ncrna.2024.07.003_bib89
  article-title: Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.21241
– volume: 6
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib28
  article-title: Proteomic analysis of circulating extracellular vesicles
  publication-title: Sci. Adv.
  doi: 10.1126/sciadv.aba5714
– volume: 25
  start-page: 981
  issue: 8
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib41
  article-title: Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis
  publication-title: Cell Res.
  doi: 10.1038/cr.2015.82
– volume: 135
  start-page: 584
  issue: 5
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib2
  article-title: Cancer statistics in China and United States, 2022: profiles, trends, and determinants
  publication-title: Chinese Med J
  doi: 10.1097/CM9.0000000000002108
– volume: 12
  start-page: 1129
  issue: 12
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib143
  article-title: Exosomal long noncoding RNA HOXD-AS1 promotes prostate cancer metastasis via miR-361-5p/FOXM1 axis
  publication-title: Cell Death Dis.
  doi: 10.1038/s41419-021-04421-0
– volume: 1
  start-page: 53
  issue: 1
  year: 2015
  ident: 10.1016/j.ncrna.2024.07.003_bib36
  article-title: Exosomal non-coding RNAs: diagnostic, prognostic and therapeutic applications in cancer
  publication-title: Noncoding RNA
– volume: 5
  start-page: 2723
  issue: 9
  year: 2014
  ident: 10.1016/j.ncrna.2024.07.003_bib64
  article-title: Oncogenic functions of IGF1R and INSR in prostate cancer include enhanced tumor growth, cell migration and angiogenesis
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.1884
– volume: 39
  start-page: 542
  issue: 4
  year: 2018
  ident: 10.1016/j.ncrna.2024.07.003_bib192
  article-title: Exosomal cargo-loading and synthetic exosome-mimics as potential therapeutic tools
  publication-title: Acta Pharmacol. Sin.
  doi: 10.1038/aps.2017.178
– volume: 16
  start-page: 156
  issue: 1
  year: 2017
  ident: 10.1016/j.ncrna.2024.07.003_bib170
  article-title: Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-017-0726-4
– volume: 21
  start-page: 145
  issue: 1
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib65
  article-title: Inhibition of cancer cell-derived exosomal microRNA-183 suppresses cell growth and metastasis in prostate cancer by upregulating TPM1
  publication-title: Cancer Cell Int.
  doi: 10.1186/s12935-020-01686-x
– volume: 2022
  year: 2022
  ident: 10.1016/j.ncrna.2024.07.003_bib66
  article-title: Integrative analysis of bulk RNA-Seq and single-cell RNA-Seq unveils the characteristics of the immune microenvironment and prognosis signature in prostate cancer
  publication-title: J. Oncol.
– volume: 57
  start-page: 540
  issue: 2
  year: 2020
  ident: 10.1016/j.ncrna.2024.07.003_bib95
  article-title: MicroRNA-137 regulates hypoxia-mediated migration and epithelial-mesenchymal transition in prostate cancer by targeting LGR4 via the EGFR/ERK signaling pathway
  publication-title: Int. J. Oncol.
  doi: 10.3892/ijo.2020.5064
– volume: 15
  start-page: 1835
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib161
  article-title: Exosomal circ-XIAP promotes docetaxel resistance in prostate cancer by regulating miR-1182/TPD52 Axis
  publication-title: Drug Des. Dev. Ther.
  doi: 10.2147/DDDT.S300376
– volume: 9
  start-page: 19723
  issue: 17
  year: 2024
  ident: 10.1016/j.ncrna.2024.07.003_bib169
  article-title: Dumbbell dual-hairpin triggered DNA nanonet assembly for cascade-amplified sensing of exosomal MicroRNA
  publication-title: ACS Omega
  doi: 10.1021/acsomega.4c02652
– volume: 18
  start-page: 116
  issue: 1
  year: 2019
  ident: 10.1016/j.ncrna.2024.07.003_bib17
  article-title: Exosomal circRNAs: biogenesis, effect and application in human diseases
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-019-1041-z
– volume: 13
  start-page: 25
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib171
  article-title: Identification of urinary exosomal miRNAs for the non-invasive diagnosis of prostate cancer
  publication-title: Cancer Manag. Res.
  doi: 10.2147/CMAR.S272140
– volume: 20
  start-page: 99
  issue: 1
  year: 2021
  ident: 10.1016/j.ncrna.2024.07.003_bib42
  article-title: Exosome-derived noncoding RNAs in gastric cancer: functions and clinical applications
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-021-01396-6
SSID ssj0001826664
Score 2.3270283
SecondaryResourceType review_article
Snippet Prostate cancer (PCa) has the highest frequency of diagnosis among solid tumors and ranks second as the primary cause of cancer-related deaths. Non-coding RNAs...
SourceID doaj
proquest
pubmed
crossref
elsevier
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1351
SubjectTerms Biomarkers
Exosomes
Modulators
Non-coding RNAs
Prostate cancer
Title Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers
URI https://dx.doi.org/10.1016/j.ncrna.2024.07.003
https://www.ncbi.nlm.nih.gov/pubmed/39247145
https://www.proquest.com/docview/3102072335
https://doaj.org/article/f6405789a2db4a2a89b2180244cc0d03
Volume 9
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3PSx0xEA7Fk5fij7Y-tZKC9ORiTLLJbm-vUhFBD6WC4CEkkw0odVfePqH97zuT3X3Yg_bS65LNDjOzzDfJzDeMHaLLhphEKEQjdYH43xc1VFCIVDeQypNYK2pOvrwy59f64qa8eTbqi2rCBnrgQXHHyRCkqGovY9Be-qoOkljLtAYQceD5xJj3LJnKpyuImo3RE81QLuhqAW2DGaHUma5zGpM1hqLM2P9XRHoJcebIc7bB3o6Qkc8HUTfZm6bdYtvzFtPlh9_8M89FnPl0fJvdjnxLPLfwUnET7xJvfnV994B7YK5fQEfhin-_mvf8ruWP1PaBgJMD2X_xhV92kUZ6dYue4x6c-vOphGfRv2PXZ99-nJ4X4_yEArQVy8KWCJ0x3UEEGEHYIJIAABnCSdC1qlKVUJXSyAhayco0ddQWc2tZRh88VFq9Z2soV7PDOKZh1lgQAi2gjbfeq4S5VaVC7W0wfsbkpEoHI7k4zbj46aYqsnuX9e9I_07QpbeasaPVS48Dt8bry7-SjVZLiRg7P0B3caO7uH-5y4yZycJuxBgDdsCt7l7_-qfJHxz-gXSt4tume-odAmQprFSqnLEPg6OsZET0idFfl7v_Q_Y9tk4CDcU0-2xtuXhqPiIkWoaD7P1_APaWB4U
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+landscape+of+exosomal+non-coding+RNAs+in+prostate+cancer%3A+Modulators+and+biomarkers&rft.jtitle=Non-coding+RNA+research&rft.au=Li%2C+Yongxing&rft.au=Tang%2C+Xiaoqi&rft.au=Wang%2C+Binpan&rft.au=Chen%2C+Ming&rft.date=2024-12-01&rft.issn=2468-0540&rft.eissn=2468-0540&rft.volume=9&rft.issue=4&rft.spage=1351&rft.epage=1362&rft_id=info:doi/10.1016%2Fj.ncrna.2024.07.003&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ncrna_2024_07_003
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2468-0540&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2468-0540&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2468-0540&client=summon